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Background: Patients living with HIV  who are on ART are faced with challenges that result 
in them defaulting taking their medication. Good adherence is required for viral suppression to 
be achieved. 
Objectives:  To identify reasons why patients are defaulting treatment and hence resulting in 
having high viral load despite being on antiretroviral treatment for at least 6 months. 
Methodology: A cross-sectional study was conducted in Mokhotlong District, Lesotho among 
the HIV patients on ART. Participants were selected from the facilities within the district. 
Three hundred and seventy-four (374) participants responded to pre-coded questions. Data was 
analysed using SPSS version 26 and Epi Infor 7.2. Frequencies, odds ratios, and 95% confi-
dence intervals, were reported.  
Results: Patients reported to have defaulted their medication due to depression AOR 4.7 95% 
CI 2.7-8.3, because they ran out of ARVs AOR 3.1 95% CI 1.4-6.2, not understanding how 
ARVs work AOR 9.3  95% CI  3.1-27.8, lost or stolen pills AOR 4.1 95% CI 1.1-14.5 , too ill 
to attend to medication refill AOR 3.8  95% CI 1.2-11.6, lack of food AOR 2.1  95% CI 1.1-
3.5, busy with other issues AOR 4.2 95% CI 2.0-8.6, travelled away from home 7.1 95% CI 
3.8-13.1, transport challenges AOR 5.8 95% CI 2.5-13.5, and fear of stigma or discrimination 
within home AOR 10.7 95% CI 4.3-26.5. 
Conclusions: Barriers to adherence need to be resolved through Health Systems strengthening 
and health promotion and education.  To achieve the 90-90-905 UNAIDS targets; there is a 
need for healthcare system modification and patient behaviour change which will aid in im-
proving adherence to antiretroviral medication. 
Word count: 264 words 
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CHAPTER 1:  INTRODUCTION 
1.1 Introduction 
Poor antiretroviral therapy (ART) adherence rates (taking less than 95% of medications as pre-
scribed) for HIV positive individuals are empirically proven to have negative outcomes (Azia 
et al.,  2016) as well as increased risk of adverse clinical outcomes (Hinkin et al., 2007) and 
this is the main reason for treatment failure and development of virological resistance (Barfod 
et al., 2006). Maintaining high levels of adherence to antiretroviral therapy (ART) is a chal-
lenge across settings and populations therefore understanding the relative importance of differ-
ent barriers to adherence will help inform the targeting of different interventions and future 
research priorities(Shubber et al., 2016). According to (Nsimba et al.,  2010), adherence is 
described as engagement and accurate participation of an informed patient in a plan of care. 
Addressing adherence issues is essential to avoid changing medications as it would be pointless 
to just change the regimens without attending to such issues (Ahmed et al., 2019). 
The concept of adherence has a broader meaning than compliance which encompasses the ex-
tent to which a patient follows instructions, implying understanding, consent and partnership 
(Nsimba et al ., 2010). It also includes entering into and continuing in a programme, or care 
plan, notably, meeting appointments and tests as scheduled. The success of antiretroviral regi-
mens demands nearly perfect adherence to medications (Palmer et al., 2003). Several factors 
contributing to poor adherence to ART have been identified in both developed and developing 
countries (Moomba and van Wyk, 2019). It is therefore recommended worldwide that all ARV 
programmes should have a concurrent plan for adherence assessment and support. Near perfect 
adherence should be defined as 95% and above adherence up to 105%. While the government 
and other players are determined to increase accessibility to ARVs, specific initiatives to pro-
mote adherence to ARVs need to be in place to ensure correct ARV use at all levels (Nsimba 
et al., 2010). 
Psychological factors, including drug abuse, alcohol addiction and mental health problems 
such as depression, have been associated with low adherence in HIV positive adults and ado-
lescents  (Nsimba et al., 2010) as well as anxiousness and lack of prescribed  treatment follow-
up (Soto Blanco et al., 2005). The prevalence of depressive symptoms among persons living 
with HIV is more than double than that found in the general population (Lima et al., 2007) and 
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interfere with important self-care behaviours such as the ability to adhere to one's medical 
treatment regimen (Vranceanu et al., 2008). The threat of social stigma may also prevent people 
living with HIV from revealing their status to others and serve as a barrier to HIV treatment 
adherence (Rintamaki et al., 2006). 
 Alcohol does not only reduce the effects of medical treatment but also puts individuals at risk 
of contracting and/ or fuelling HIV and AIDS (Nsimba et al., 2010) and has been associated 
with missed pills during follow-ups (Mellins et al., 2003). It is not easy to understand that 
alcohol consumption may influence negatively a person’s capacity to follow up a strict medi-
cation regimen. Intoxication, be it on single occasions or regularly, leads to reduced self-control 
and in difficulties to follow up on routines and duties. Furthermore, heavy drinking is often 
associated with a less regular life style and problems to follow up daily care, resulting in bad 
nutritional state and poor sanitation, etc. (Nsimba et al., 2010). 
HIV/AIDS remains a significant factor in the social and economic development of many coun-
tries, specifically many in Sub-Saharan Africa (SSA). In Lesotho, HIV prevalence is 23.8% 
and is the leading cause of death (Avert, 2019). Because adherence to treatment is a critical 
factor in the success of ART, attention to all factors; such as external, structural factors and 
cultural, as well as internal, behavioural and individual factors which could prevent adherence 
should be identified and addressed. 
1.2 Background 
In Lesotho 74% of all those living with HIV are on treatment. The percentage of people on 
treatment who were virally suppressed in 2017 was 68% (Avert, 2019). Stigma remains a bar-
rier to HIV testing and treatment, particularly among men and people from key populations 
which are people that  are at higher risk of  being infected with HIV due to their risky behaviour 
such as female sex workers etc. Antiretroviral treatment (ART) coverage in Lesotho has been 
increasing in recent years, and in 2016, 53% of  HIV positive  adults were accessing treatment 
(Avert, 2019). Global targets for scaling up antiretroviral therapy (ART) include ensuring that 
90% of patients on ART achieve viral suppression. This gives a renewed emphasis to ensuring 
optimal levels of adherence. Negative outcomes of longer-term suboptimal adherence include 
increased risk of disease progression, drug resistance, high viral load and consequent risk of 
transmission, and death (Shubber et al., 2016).  
3 
 
Maintaining high levels of adherence is a challenge across settings (Nsimba et al., 2010). 
Suboptimal adherence to antiretroviral medication has been reported for specific patient groups 
such as adolescents, pregnant women, and others in high-, middle-, and low-income countries. 
A broad range of context-specific barriers to adherence have been reported, including forget-
fulness, stigma, adverse drug reactions, and competing responsibilities (Shubber et al., 2016). 
These challenges have been categorized as individual, interpersonal, community, and structural 
factors (Shubber et al., 2016). Literature has consistently revealed that socio-economic varia-
bles such as unemployment, poverty, food insecurity and transport costs are implicated in poor 
adherence to ARV medications (Azia et al.,2016). 
A qualitative study was conducted in six selected hospitals of Addis Ababa by Biadgilign et al. 
(2009), which explored barriers and facilitators to antiretroviral medication adherence among 
HIV-infected paediatric patients. Twelve caregivers of adherent and non-adherent children and 
14 key informants in  six hospitals were included in the study. The findings revealed that over-
dosage (heavy pill burden), fear of stigma and discrimination, cost and access to transportation, 
lack of understanding of the benefit of taking the medication, economic problems in the house-
hold, and lack of nutritional support were the barriers to adherence to Highly Active Antiretro-
viral Treatment ( HAART). The presence of mobile/wall alarm, the presence of follow-up 
counselling, improved health of the child, ART clinic setups, and disclosure of HIV serostatus 
were among the facilitators (Biadgilign et al., 2009) . The  study conducted by Biadgilign et al. 
(2009),  indicated that paediatric adherence to antiretroviral therapy faces a huge challenge. It 
suggests the provision of income-generating schemes to caregivers for assisting HIV-infected 
children. Health-care providers should address proper usage of medication reminders. 
In a study conducted among inmates by  Farhoudi et al. (2018), participants reported illegal 
drug use, poor education in HIV treatment, side-effects of antiretroviral drugs, treatment inter-
ruption, drug interferences, fear of hangover, poor diet, poor socioeconomic background, hope-
lessness, depression, not believing in the treatment, rejection and lack of social support, stigma, 
compulsory rest in the yard, lack of tendency toward visiting psychiatrists, lack of familial 
support, forgetfulness, and not receiving complementary drugs as the barriers to adherence to 
ART. In addition, the facilitators were physician-patient good relationship, physician’s com-
passion, counselling services for the patients, education of patients regarding HIV treatment 
necessities, peer education, informing patients about their CD4 levels, education of correctional 
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staff to show courtesy in the treatment of patients, timely methadone therapy, and improved 
diet. 
Results from the qualitative discussions that were conducted in Tanzania revealed that, indi-
vidual as well as institutional factors contributed to non-adherence. For many; food, long wait-
ing time, transportation, social supports, lack of education about anti-retroviral therapy (ART) 
or ARVs, lack or inadequate counselling, drug related side effects, and even knowledge about 
AIDS were barriers. Structural impediments such as stigma by untrained hospital care workers 
towards clients, over-worked health-care staff, and lack of space for confidential consultations, 
lack of availability of diagnostic and laboratory equipment were also cited as barriers (Nsimba 
et al., 2010). However, according to health staff, adherence was interpreted to mean using med-
icines as prescribed, at the right time and at the correct dosage, and attending the facilities as 
scheduled for follow-up checks (Nsimba et al., 2010). 
1.3 Problem statement 
Lesotho is a small country with a population of 2.2 million and it is the second  in the world  
hit by  the HIV pandemic with HIV prevalence of 23.8% in 2018. In 2019, 340 000 people 
were living with HIV in Lesotho (Avert, 2019). HIV testing and treatment coverage have im-
proved in the country, however there are challenges which patients on ARVs face that hinder 
them from taking their treatment effectively. 
Since 2016, when Lesotho started the routine viral load monitoring, there are patients that have 
been on antiretroviral medication for more than 6 months and despite having been on treatment, 
their viral load is above 1000 copies/ml and it is suspected this is because of defaulting. The 
2016-2017 Lesotho Population based Health Impact Assessment (LePHIA) results showed that 
in Lesotho viral suppression is at 67.8% and Mokhotlong District had the viral suppression of 
58.8 % and thus this district’s status is far from the 2020 targets set by the UNAIDS of world 
populations reaching 90% detection, 90% on antiretroviral drugs, and 90% individuals being 
viral-load suppressed (90-90-90). 
These statistics necessitated this study to be conducted as to identify why patients are not taking 
their treatment as expected. The study aims to understand why there is a problem with default-
ing on ARVs in Mokhotlong District  and identify barriers related to defaulting so that the 




 1.4 Aims and objectives  
The aim of this study was   to determine the prevalence of and associated factors of treatment 
default among patients under antiretroviral medication in Mokhotlong District, Lesotho. 
 
1.4.1 Study Objectives 
1. To quantify prevalence of defaulting antiretroviral treatment in study population. 
2. To explore reasons why patients that have been on treatment for 6 months or more have 
high viral load despite being on antiretroviral medication in Mokhotlong District. 
3. To determine the relationship between defaulting treatment and high viral load among 
patients who are on antiretroviral medication. 
4. To identify if defaulting antiretroviral treatment and high viral load differ by socio-demo-
graphic factors in Mokhotlong District. 
5. To identify if economic and cultural factors contribute to poor adherence to antiretroviral 
treatment. 
 
1.5 Research questions 
 
1. What is the prevalence of defaulting antiretroviral treatment among study participants? 
2. What is the relationship between defaulting treatment and high viral load among pa-
tients that are on antiretroviral medication? 
3. Does the defaulting differ by socio-demographic factors in Mokhotlong District? 
4. Do economic and cultural factors contribute to poor adherence among patients with 
high viral load in Mokhotlong District? 
5. Why are patients that have been on treatment for 6 months or more have high viral load 
despite being on antiretroviral medication? 
 
1.6 Study Hypothesis 
The high rate of defaulting is related to high viral load and cultural factors. The null hypothesis 
(H0) indicates no association between the two independent variables in the study and the alter-




1.6.1 Specific research hypothesis by objectives  
1. To assess if patients that have been on treatment for 6 months or more have high viral load 
despite being on antiretroviral medication at Mokhotlong Hospital. 
H0:  There in no association between being on antiretroviral treatment for 6 months and viral 
load 
HA: There is an association between being on antiretroviral treatment for 6 months and viral 
load 
 
2. To determine if there is a relationship between defaulting treatment and high viral load 
among patients that are on antiretroviral medication. 
H0:  There is no relationship between defaulting treatment and high viral load among patients 
that are on antiretroviral medication 
HA: There is a relationship between defaulting treatment and high viral load 
 
3. To identify if defaulting antiretroviral treatment and high viral load differ by socio-demo-
graphic factors in Mokhotlong District. 
H0:  Defaulting antiretroviral treatment does not differ by socio-demographic factors in 
Mokhotlong District 
HA:  Defaulting antiretroviral treatment differs by socio-demographic factors 
 
4. To identify if economic and cultural factors contribute to poor adherence to antiretroviral 
treatment. 
H0:  Economic and social factors do not contribute to poor adherence to antiretroviral treatment 
HA:  Economic and social factors contribute to poor adherence to antiretroviral treatment 
 
1.7 Feasibility of the study 
The study was feasible as it was conducted among participants that access HIV services in the 
selected health facilities that were part of the study. The research assistants that assisted in 
giving and receiving the questionnaires were workers in the same health facilities and hence 
the work was easily done. The participants were given some questionnaires to provide infor-
mation on why they default treatment and they were able to respond to the questionnaires while 
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in the clinic and some took the questionnaires with them home and brought them back on their 
next appointment. 
 
1.8 Purpose and importance of the study 
The purpose of the study was to identify reasons why patients are defaulting ARV treatment 
for HIV/AIDS and hence result in high viral load despite being on treatment for at least 6 
months. The results of the study will aid in better management of patients with high viral load 
as barriers would have been identified. Treatment adherence is generally regarded as an im-
portant factor in achieving optimal outcomes across many disease states in the treatment of 
HIV/AIDS; poor adherence to treatment has the potential to impact outcomes on multiple lev-
els. Poor adherence to antiretroviral therapy (ART) is associated with less effective viral sup-
pression, which risks the immediate health of the patient, but also risks creating permanent 
treatment resistance to that particular agent or group of agents within a given combination 
therapy regimen. Poor adherence to antiviral medication accelerates development of drug-re-
sistant HIV. Therefore, identifying and overcoming the factors that reduce adherence to com-
bination antiretroviral agents is of utmost importance for prolonged viral load suppression 
(Chesney, 2000). This may have downstream effects on treatment costs as well as therapeutic 
options, as a result identifying barriers to adherence to antiretroviral medication will aid in 
lowering chances of patients being switched to second line regimen and enhance patient’s man-
agement accordingly so that they do not default treatment. 
 
1.9 Significance of the study  
Lesotho has been providing viral load monitoring test to patients who are clinically or immu-
nologically failing treatment and sometimes such test would be done only when a patient’s 
condition is deteriorating. However, as of June 1, 2016, routine Viral Load (VL) monitoring 
has been made available to all patients on antiretroviral treatment (ART). The National ART 
guidelines have been recently revised and they recommend VL testing six and 12 months after 
ART initiation followed by annual testing thereafter if the viral load is suppressed. The routine 
VL monitoring scaling up was expected to cover 50% of patients on ART by end of 2016 and 
>90% by end of 2017 (Nyagadza et al., 2019). Globally, countries are working towards the 90-
90-90 targets by 2020 which were set by the UNAIDS, thus Lesotho is not an exception in 
aiming to reach the same statistics. There are many patients that have high viral load despite 
being on ART for 6 months or more, so this study focuses mainly on finding why this is so. If 
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many patients are defaulting treatment, they will remain with high viral load and there is then 
an increased risk of HIV re-infections and resistance; and thus, there will be high incidence of 
HIV. Already Lesotho’s HIV prevalence among people aged 15-49 is 24.6% and annual inci-
dence is 1.9% (Mengistu et al., 2016) and thus making it the second highest affected with HIV 
in the world after   Eswatini. As a result, finding problems of defaulting on ARV treatment 
would aid the country in reaching the third 90% target.  
 
In a study by Wasti et al. (2012), lack of knowledge and negative perception towards ART 
medications significantly affected non-adherence. Transport costs (for repeat prescription), fol-
lowed by pills running out, not wanting others to notice, side-effects, and being busy were the 
most common reasons for non-adherence. This study mainly focuses on patients that have viral 
load results not all patients on ART as other researchers have already looked at those aspects. 
The results of this study can aid in better knowledge of challenges that result in poor adherence 
among patients with high viral load and lead to the appropriate management for this patients 
and aid policy makers to review management of patients following the study results. Finding 
and resolving barriers to adherence thereby aiding better management of HIV/AIDS patients  
can save the country funds of patients that would have had to be switched to second line or 
third line regimen which are more expensive and also complex to take.  
 
1.10 Delimitation of the study 
The study identifies why high HIV viral load patients and virally suppressed  are defaulting 
treatment and identify the barriers related to this situation. The study was conducted in the 
district of Mokhotlong, Lesotho and was conducted in the eight clinics being Malefil-
loane,St.james ,Libibing ,Moeketsane ,Linakaneng ,Molika-liko,Mapholaneng and St.Martins 
and one hospital situated in the district. The main participants of the study were patients that 
are on HIV antiretroviral medication for 6 months or more and their blood tests show viral load 
above 1000 copies/ml or viral load less than 1000 copies/ml. The main participants were both 
males and females aged 18 years and above. Data collection was in the form of questionnaires 
that were given to the participants and they were requested to respond to the questionnaires and 
after answering the questionnaires return them to the nurses and counsellors that work in the 




1.11 Summary and transition 
In Lesotho, 74 % of patients are on HIV antiretroviral medication, and as a result all these 
patients are expected to be virally suppressed as they are expected to be taking their ARV daily. 
However there are barriers that are associated with not taking at least 95% of the prescribed 
regimens and studies that have been conducted in other countries identified different barriers 
to adherence. Due to the unexpected high HIV viral load in Lesotho there is therefore a need 
to conduct a study to identify if patients experience the same barriers. The study will be visible 
as it was conducted among facilities in Mokhotlong District, a district with high defaulting 
rates. A literature search from other countries that have conducted studies on barriers to adher-
ence as to learn of what was found was carried out, hence we move to the literature review and 




CHAPTER 2: LITERATURE REVIEW 
 2.1 Introduction  
This chapter presents the literature on barriers to adherence to antiretroviral medication. The 
chapter is divided into three sections; first section is the conceptual frame work, second sec-
tion is the literature search strategy and the last section literature review on barriers to adher-
ence. 
 2.2 Conceptual framework 
A conceptual framework is the total, logical orientation and associations of anything and eve-
rything that forms the underlying thinking, structures, plans and practices and implementation 
of the entire research project (Kivunja, 2018). 
 
2.2.1 Health belief model  
Health belief model is a psychological health behaviour change model developed to explain 
and predict health-related behaviours, particularly in regard to the uptake of health services. 
This model is comprised of several components: perceived susceptibility, perceived severity, 
perceived benefits, perceived barriers, cues to action and self-efficacy (Razmara et al., 2018). 
Figure 1 below illustrates the Health Belief Model and figure 1.1 depicts conceptual frame 




Figure 1: Health Belief Model (Source: (Urich,2017) 
The HBM’s eight components as they pertain to HIV treatment adherence: 
1. Perceived Susceptibility: -Perceived susceptibility refers to subjective assessment of risk of 
developing a health problem. The HBM predicts that individuals who perceive that they are 
susceptible to a particular health problem will engage in behaviours to reduce their risk of 
developing the health problem (Urich, 2017). HIV patients are likely to engage in behaviour 
change when they belief that they are susceptible to AIDs and thus are likely to change their 
behaviour by adhering well to their antiretroviral medication. 
2. Perceived Seriousness: -Perceived seriousness encompasses beliefs about the disease 
itself (e.g., whether it is life-threatening or may cause disability or pain) as well as broader 
impacts of the disease on functioning in work and social roles . The HBM proposes that 
individuals who perceive a given health problem as serious are more likely to engage in 
behaviours to prevent the health problem from occurring(Urich, 2017). This perception can 




3. Perceived Benefits: -Perceived benefits refer to an individual’s assessment of the value or 
efficacy of engaging in a health-promoting behaviour to decrease risk of disease. If an 
individual believes that a particular action will reduce susceptibility to a health problem or 
decrease its seriousness, then s/he is likely to engage in that behaviour (Urich, 2017). 
Patients are more likely to adhere to medication if they know that through good adherence 
they will live long and be able to take care of their loved ones. 
4. Perceived Barriers: -Perceived barriers refer to an individual’s assessment of the obstacles 
to behaviour change. Even if an individual perceives a health condition as threatening and 
believes that a particular action will effectively reduce the threat, barriers may prevent 
engagement in the health-promoting behaviour (Urich, 2017). Lack of transport to the health 
facilities can lead to patients not accessing their treatment. Pill burden or the complicated 
dosing may result in patients taking suboptimal treatment and hence result in high viral load. 
5. Cues to action: -HBM posits that a cue is necessary for prompting engagement in health-
promoting behaviours (Urich, 2017). Patients adherence to treatment medication may be 
influenced by external factors such as family support which in turn can result in improved 
adherence. 
6. Self-Efficacy: -Self-efficacy refers to an individual’s perception of his or her competence to 
successfully perform certain behaviour. Self-efficacy was added to the HBM in an attempt 
to better explain individual differences in health behaviours (Urich, 2017). Patients will 
likely adhere or not adhere to medication depending on their perception on effect of the 
disease. 
7. Perceived threat: Health belief model predicts that higher perceived threat leads to higher 
likelihood of engagement in health-promoting behaviors (Urich, 2017).Patients will adhere 
to their medication if they are knowledgeable about the disease . 
8. Modifying variables : The health belief model suggests that modifying variables affect 
health-related behaviors indirectly by affecting perceived seriousness, susceptibility, 
benefits, and barriers (Urich ,2017).Patients age , sex ,and education can have an effect on 








Application to the study  
 
                                          
 












Figure 1.1: Conceptual framework of the study 
Based on  the objectives of the study the conceptual framework was developed(see figure 
1.1).The structure shows that defaulting medication can be influenced by different factors such 
as the individual factors which includes forgetting medication, depression, fear of stigma, and 
being busy with other things, Socio-demographic factors which include age, sex and education, 
cultural and economic factors such as religion, employment and income . Defaulting 
Individual factors  
-Forgeting medication 
-Depression 
-Fear of stigma 








graphic factors  
-Age  
-Sex 
_Education Defaulting  
High viral load  
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medication as depicted in the diagram  by use of arrows may  result in high viral load and socio-
demographic factors as based on the study objectives . 
2.3 Literature search strategy  
 
Literature search was done through the research articles and the databases which include the 
Pubmed, BMJ journals and PMC and articles that are published online. The data was collected 
on articles published between year 2000 and 2019 because  during that period there was an 
increase in HIV infections which resulted in more studies to be conducted and they are the 
most recent articles which gives the most recent updates on HIV. The search included terms 
related to HIV, ART, adherence, and barriers. The searches were limited to English-language 
publications on research done on human adults from age 18 and older. The title and abstract of 
each record were screened and the full texts of all potentially relevant records were examined. 
Records of conference abstracts and opinion articles were excluded. 
 
2. 4 LITERATURE ON BARRIERS TO ART ADHERENCE 
 
Sub-optimal adherence to antiretroviral medication remains common (Engler et al., 2018). 
However, antiretroviral medications are to be taken consistently by patients so that they can be 
virally suppressed, and with viral load suppression illnesses and mortality associated with HIV 
can be reduced. Unfortunately, this is a lifelong treatment therefore there are some barriers that 
hinder patients from adhering well to treatment. 
 
 2.4.1 Adherence 
Antiretroviral therapy (ART) is becoming increasingly available to people in developing coun-
tries, therefore adherence challenges assume ever greater significance. According to Eyassu et 
al .(2016), introduction of antiretroviral therapy (ART) has shown reduction in HIV-related 
mortality and morbidity in people living with HIV and AIDS. High levels of adherence are 
required for viral suppression and 95% of adherence needs to be achieved. Studies are therefore 
done to identify whether patients are doing what is expected of them as a way to finding out 
some of the challenges patients come across in taking the life-long treatment to find solutions 
to such challenges. Farhoudi et al. (2018) identified illegal drug use, poor education in HIV 
treatment and side effects of antiretroviral medication as barriers to adherence among inmates.  
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In 2017, a study conducted by Croome et al. (2017) showed the following as the major barriers 
to adherence: forgetting, lack of access to adequate food, stigma and discrimination, side ef-
fects and being outside the house or travelling. Eyassu et al. (2016) identified frequent facili-
tators to adherence as social support, reminders, feeling better or healthier after taking ART, 
disclosing their HIV status and having a good relationship with a health provider. As a result, 
research findings from studies have necessitated this study to be conducted in Lesotho, espe-
cially in the highlands such as Mokhotlong District to identify if the same barriers to adherence 
and facilitators of good adherence apply. Adhering well to ART medication can be affected by 
the individual, structural and medication factors hence if these are identified patients can be 
assisted on how best they can deal with the challenges they face that hinder them from adhering 
well to treatment. 
 
2.4.2 Health system barriers 
A health system by itself can be a barrier to patients’ adherence even though the expectation is 
for it to ensure good quality services that save patients’ lives. In a study conducted by Azia et 
al . (2016), health system related factors included; poor treatment literacy, patients who lacked 
awareness that by their not adhering well to their medications there are adverse outcomes to 
not adhering well to treatment were more likely to default treatment, lack of follow-up of pa-
tients led to their feeling neglected, patients even feared going back to the clinics for fear of 
being shouted to by the health workers as to why they missed their appointments, dissatisfac-
tion with the quality of the ART services provided by the healthcare system leading to more 
likelihood of defaulting on treatment. 
Lack of confidentiality in the way patients’ HIV results were handled as when patients would 
be given their laboratory results in the presence of others.  This practice make patients feel 
disrespected and their privacy not honoured, and this behaviour by health professionals is not 
ethical (Azia et al ., 2016). Lengthy waiting times at ART clinics due to staff shortages of staff 
within the health care system result in patients fearing picking up other infections from other 
patients in the outpatient department.  The long waiting periods result in some patients missing 
work as they have to wait for one nurse to offer them services who sometimes gets over-
whelmed by workload. The study therefore aims identify if these challenges also apply in 
Mokhotlong District. The results of the study can give guidance to better healthcare for HIV 
patients. Additionally, some health facilities are far from the villages where patients stay and 
most times without transport hence this could be another factor at play. The study above, that 
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was conducted in Western Cape, South Africa by Azia et al (2016), did not look in possible 
impacts to treatment defaulting related to distance.  
Furthermore, Dewing et al. (2015), opposed to the results found above, reported structural bar-
riers such as distance to the health facility were not a challenge with regard to adherence to 
treatment. However, these results have to be reviewed in the context of Lesotho in whether 
health system does or does not have an impact to patients’ adherence to ART. In a study con-
ducted by (Kagee & Delport, 2010) institutional barriers identified were; long waiting times at 
clinics, negative experiences with clinic staff, which if not attended to result in high defaulter 
rates. 
 
Regular availability of the antiretroviral drugs and their accessibility are important factors that 
affect adherence ( Anyaike et al., 2015). Hence, there is need to find the impact of this on 
patients adherence as most of the time it is the patients who blamed for not adhering well to 
treatment, while if it is not the case finding out healthcare system challenges would assist the 
MOH, Lesotho to act accordingly. 
 
2.4.3 Stigma and discrimination 
Stigma and discrimination were identified as barriers to adherence to ART treatment amongst 
infected males and females in  Vredenburg regional hospital Western Cape South Africa (Azia 
et al., 2016). Patients discontinued treatment because they experienced depression as they were 
not supported by their family members and friends (Azia et al ., 2016). Due to lack of support 
they resorted to missing their treatment. Even in current times with the increased ART cover-
age, patients are still not supported although much education about stigma and discrimination 
has been carried out as compared to the late 90s when people were not well educated about 
HIV and its related spread. The study by Azia et al . (2016) did not find that employers con-
tributed to patients defaulting treatment.  It is therefore  necessary to find out what other factors 
contribute to poor adherence  if healthcare professional and employers do not discriminate 
patients that are on ARVs.  
Stigmatization is one of the factors that contributes to varying adherence among patients that 
are on ART. A study by Anyaike et al. (2019) reported that between 3.5% and 14.6% of women 
in Africa are subjected to violence by males when they report their HIV status or disclose that 
they are on ART. There is therefore a need to find the level of violence in Lesotho as a result 
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of reporting that one is on ART and the impact that it has on the patients’ adherence to treat-
ment. The necessary education can be strengthened in collaboration with other ministries so 
that such cases are reported and dealt with. Reports have also revealed the extent to which 
people are stigmatized and discriminated against by the healthcare workers and the health sys-
tem. Stigmatization as a factor against optimal treatment adherence has been documented often 
(Anyaike et al., 2019) and hence a need to find out if in Lesotho that is also the case. 
2.4.4 Economic and cultural barriers 
Economic barriers identified in a study by Groh et al. (2011) showed that in all the groups that 
were included in the study, were barriers to procurement food and transportation. Seventy eight 
per cent (78%) reported inability to afford and procure quality or sufficient food, thus with the 
inability to get to the clinics due to inadequate finances for bus/taxi fare they ended up default-
ing on their HIV treatment. They also reported that they often experienced increased appetite 
and without adequate supplies of food they then do not take their medication for fear of expe-
riencing hunger. As Lesotho is among the African countries that are stricken by poverty and is 
a low economy country it would be therefore important to find the impact of unavailability of 
food on HIV treatment adherence. 
 
Cultural background and environment in which people live may influence reasons for adher-
ence. Some studies reported statistically significant barrier differences by race, with whites 
more likely to report that medications were inconvenient, and that they were taking more med-
ication than desired. African Americans were more likely to report they had no storage place 
for medication, they ceased medications when they felt better, they did not take medications 
when away from home, and they were embarrassed to get refills (Murphy et al .,2003). Hence, 
there is need to find out whether in Africa, especially in Lesotho, if the same reasons apply. 
Cultural factors that are negatively affecting patients’ adherence to antiretroviral medication 
include use of traditional medicines which leads to some patients no longer taking their treat-
ment or possibly lead to drug to drug interaction as the ingredients in the traditional medicines 
used are not known and not scientifically tested (Denison et al., 2015). In Lesotho, there is 
widespread use of traditional medicine and this leads to patients defaulting on ART treatment 
believing they will be cured by these medicines. Finding out the level at which such medicines 
are used would therefore be of great importance for further research focusing on the specific 
drugs that individuals take with the belief that they cure HIV. Other cultural barriers identified 
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by Kagee & Delport (2010) included the role of traditional healers’ practices when they claim 
to be able to cure HIV and patients’ adherence to treatment. Charismatic churches and their 
claim to cure HIV and their influence were also identified as barriers to treatment adherence. 
Testing their impact in ART uptake and patients defaulting treatment will also be important. 
 
2.4.5 Social barriers 
Azia et al. (2016) identified socially related factors that hindered adherence to ART as fear of 
unintended disclosure by being in the ART clinics/corners as by being in such places automat-
ically shows that one is on the lifelong ARV medication. Consequently, some patients end up 
not attending clinics and some go to the clinic in the afternoon when most of the other patients 
have left the clinic. Farhoudi et al. (2018) found that stigma by other inmates ,correctional staff 
and health care workers resulted in HIV positive  inmates to default their medication .Finding 
out how and whether this has an impact to adherence to treatment is needed. Community HIV 
healthcare providers were also identified as barriers to adherence as being seen with them is 
associated with taking treatment. Patients usually end up denying interacting with community 
healthcare providers as they are appointed as treatment supporters to patients. HIV positive 
individuals end up defaulting on their treatment as they do not want to disclose indirectly to 
the society through the association with community healthcare providers. Fear of being humil-
iated by other community members was also identified as a barrier because once one’s status 
is known in the community; the person is discriminated against.  
Lack of family care, depression, alcohol use and social stigma were identified as barriers to 
adherence to antiretroviral therapy therefore some patient’s social life can have impact on their 
adherence (Achappa et al., 2013). This is supported by Azia et al.(2016), who also found that 
patients discontinued treatment because they experienced depression as they were not sup-
ported by their family members and friends. This necessitated a study which came up with 
measures that can be implemented as to ensure support by either family or friends. 
 
 2.4.6 Poverty and unemployment  
In Lesotho, outreach programmes are done in most districts for child vaccinations however 
they are not comprehensive enough to include HIV services. This is due to inadequate trained 
human resources and as result patients have to travel to the health centres for health services. 
In most cases patients do not have enough transport money to attended check-ups. In studies 
conducted in other countries, many respondents reported that they sometimes failed to take 
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their ART because they did not have money for transport (Anyaike et al., 2019). They did not 
have money to access services especially when they needed to travel long distances to health 
service centres. Hence, it is important to find if most patients that do not adhere to treatment 
stay near or far from the clinics or health facilities.  
Due to poverty some patients are not able to buy food and as result they do not take their 
treatment well as they believe that the HIV medication they take exacerbate hunger hence as a 
result they miss some doses (Azia et al. , 2016).  There is therefore need to find out if unavail-
ability of food lead to high viral loads as patients are not taking their treatment properly. Kalich-
man, Kalichman and Cherry (2015) reported that people living in poverty face multiple struc-
tural challenges to medication adherence including lack of transportation, inadequate housing, 
and food insecurity. Hence, it will be of great interest to have an idea if indeed poverty has a 
major impact on adherence to ART. Furthermore, Kagee & Delport (2010) reported poverty-
related barriers as transport difficulties, food insecurity and patients’ receipt of a disability 
grant. Finding out if the above pertain to Lesotho, as there are also disability grants offered, 
will assist in clarifying the picture of barriers to adherence to HIV medication in the country. 
 2.4.7 Fear of unintended disclosure of HIV status 
Adherence to ART is important for long -term therapeutic success and of major concern in HIV 
programme as it result in improved health status of the patients (Kassahun and Zalalem, 2018). 
. The results of the study  by Panda et al.( 2015) found that unintended disclosure to the family 
members contributes to poor adherence as a  number of patients reported that they discontinued 
accessing the ART clinic because they were afraid that their status could be unintentionally 
disclosed if they were seen queuing up at the ART clinic regularly.. In some facilities ART 
patients are consulted at specialised HIV/AIDS clinics and hence being seen there is automat-
ically associated with being ART patient. This had been found to have an impact to treatment 
adherence in other countries; this study could find out if that is the case in Lesotho. In the study 
by (Panda et al., 2015)  one of the respondents who was 60 years pointed out that if someone 
was often seen in the community having lengthy discussions with any HIV-care provider, that 
person’s HIV status was automatically assumed and this caused some patients to miss im-
portant appointments with HIV-care providers.  
Socially related factors that were identified by the respondents to hamper adherence to ART 
were fear of unintended disclosure when using the ART clinic, fear of unintended disclosure 
when seen interacting with community HIV-care providers, fear of unintended disclosure 
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leading to the secret trade on ART (Azia et al.,  2016). As a result, once a patient is seen by a 
friend or family member whom she/he does not want to disclose to might end up defaulting 
treatment. A study is needed to find what has to be done so that patients do not disclose unin-
tentionally and end up missing appointments.  
2.4.8 Lack of follow-up 
The study conducted in Western Cape, South Africa by Azia et al .(2016) found from one of 
the respondents who had missed his ART appointment due to inadequate follow-up by the 
nurse in charge at the rehabilitation unit and consequently his medication ran out without the 
nurse realising that he missed his pills for 4 days. There is therefore a need to find out how 
patients are followed up when they are admitted in the hospitals or rehabilitation centres so that 
quality services can be offered. It is important that patients do not feel neglected while they are 
in the care of the healthcare workers. By not following patients closely, the patients end up 
having treatment failure, yet they were with the healthcare workers whom the expectation is 
they ensure that patients are well taken care of. 
2.4.9 Lack of money for transport 
The study that was conducted in Western Cape, South Africa by Azia et al . (2016) found that 
taxi fare to and from the ART centre at the time of the study was R36.00 and resulted in some 
patients not being able to pick their medication . One of the respondents from the study con-
ducted by Nsimba et al. (2010) reported to have missed his scheduled appointment and due to 
lack for transport . Furthermore, Kagee & Delport (2010) also found lack of transport was a 
barrier to adherence as patients missed appointments. In Mokhotlong District, transport is ei-
ther by taxi or a horse ride therefore a study is needed as to find out if indeed transport fare or 
not having a horse to go to the health facility is a barrier to adherence to treatment which result 
in missing scheduled appointments. 
2.5 Summary and transition 
Barriers to adherence to antiretroviral medication differ depending on individuals, and barriers 
are influenced by individual, structural and medication factors. Cultural factors and economic 
factors which include lack of transport to the clinic and lack of funds to buy food have a nega-
tive impact on patients’ adherence. Social factors also contribute to poor adherence and having 
identified the barriers;  the next step is how this study can have impact on HIV patients and the 
Lesotho Ministry of Health’s management of the HIV/AIDS epidemic in the country. 
21 
 
CHAPTER 3: METHODOLOGY 
 
3.1 Introduction  
 
This chapter presents the research methodology used in the current research study. It focuses 
on the study design, study site, study population, sample size. It also explains the data types, 
data collection methods, pilot study, validity, reliability, and ethical considerations.  
 
3.2 Study design 
 
The selected study design was Cross-sectional as the study was descriptive in nature and 
focused on patients with high viral load as compared to those with low viral load which is the 
common characteristic. A quantitative method using coded questionnaires was used to collect 
data from patients with high viral load and also those who were virally suppressed during the 
collection period. Participants were selected depending on the inclusion and exclusion criteria 
for the study. Barriers to adherence to antiretroviral medication were identified hence the 
selected study design. Defaulting treatment was the exposure variable and the outcome were 
the viral load and this was a short duration study. 
 
3.3 Study site 
 
The study was conducted in Lesotho, a country in Southern Africa with ten districts (Figure 2). 
The study was conducted in Mokhotlong District which is located in the mountains as Lesotho 
is mostly a mountainous kingdom. There are 12 health facilities in the district, however the 
study was conducted in 9 facilities that are mostly supported by Ministry of Health (MOH) Red 
Cross and Christian Health Association of Lesotho (CHAL). These are St. James, St. Martins, 







Figure 2: Lesotho map 
Source: https://www.researchgate.net/figure/Map-showing-the-ten-administrative-districts-of-
Lesotho-districts-and-the-topographical_fig1_328506112[Accessed 26 Sep.2019] 
 
3.4 Target population 
 
The study focused on patients that were on antiretroviral medications for 6 months or more and 
were accessing their health care management in the selected health facilities in Mokhotlong 
District. For patients to be part of the study they had to meet the inclusion and the exclusion 
criteria of the study. Both males and females took part in the study. 
 
3.4.1 Study population 
As of 2016 census, the population of Mokhotlong District was 100,442 (Anon, 2019). The 
country has two official languages being Sesotho and English , however  majority of the 
population speak Sesotho, as it is one of the official languages in the country, and are mostly 
Basotho. The study included 374 participants who were HIV positive and who were accessing 
services in the selected health facilities. One hundred and eighty-seven (187) were patients with 
viral load above 1000 copies and 187 were those with viral load below 1000 copies after six 
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months or more of antiretroviral medication treatment. The study focused on HIV positive 
patients accessing health services in the district and on those with available viral load results. 
The study was conducted among patients that are 18 years and older.  
 
3.5 Sampling 
The purposive sampling which is a non-probability sampling strategy was used to select par-
ticipants of the study. As patients visited the health facilities for their monthly refills,  they 
were informed about the study, and those who were willing to participate were given an oppor-
tunity to participate. Patients with available viral load results were able to take part in the study. 
From those who participated; cases and controls were identified. 
 
3.6 Sample size estimation 
Sample size estimation was calculated using the Centres for Disease Control and Prevention 
(CDC) EPINFO program for analytic cross-sectional study Version 7.2.  
 
.Figure 3: Sample Size Estimation Using EPINFO 7.7 
 
The study included a total of 374 participants of which 187 were patients with a viral load 
>1000 copies/ml and the other 187 were patients with a viral load <1000 copies/ml making it 
a ratio of 1:1 cases to controls. The sample size is determined using odds ratio of 2.80 power 
and 95% confidence interval, 20% outcome in unexposed and 33.3% outcome in exposed, 20% 
contingency plan is used for  potential lost to follow and total will be 374 participants of which 
187 will be patients with a viral load >1000 copies/ml and the other 187 will be patients with 




3.7 Inclusion criteria 
For participants to be included in the study, they had to be accessing HIV chronic care services 
at the health facilities in Mokhotlong District for 6 months or more and had drawn their viral 
load samples in such facilities. One had to be HIV positive, been on HAART for 6 months or 
more, had a viral load result of >1000 copies or a result of < 1000 copies, be 18 years of age or 
older and be able to give consent either by writing or thumb stamp in the presence of a witness. 
 
3.8 Exclusion criteria 
For people to be excluded from the study; they were not accessing their HIV medication from 
the selected facilities or if they accessed their  HIV chronic care services from the study’s 
selected facilities in Mokhotlong District but were very ill and could not give consent and be 
able to answer questions, psychiatric patients who were not stable enough to consent and an-
swer questions, age below 18 years and inability to give consent to participate in to the study. 
 
3.9 Data types  
Quantitative data was collected using the coded questionnaires. The type of data included in-
terval data which entailed viral load results, age ranging from 18-100 and the distance in hours 
travelled to the health facility. Nominal data included whether patients are males or females, 
whether they stay in rural or urban areas, the language used and the employment status, de-
faulting prevalence. Ordinal data mainly included the education level of the participants from 
no education to tertiary level. And lastly, ratio data which included the income of the partici-





Table 1: Variables and coding 
Type of variable Description Type of data How measured  
Dependant variable  
Defaulter rate  
Defaulting preva-
lence 
How many times treatment was 
missed  
Nominal Never                   1 
1-3 times              2 
More than 3times 3 
Independent variable  
Laboratory test 
Viral load  Viral load results above 1000 
copies and below 1000 copies  
Interval VL >1000        1 
VL < 1000       2 
 Confounders  
Socio-demographic factors  
Age  18-100 Interval Categorised as : 
18-39                1 
≥40                   2 
Gender  Male 
Female  
Nominal  Male                 1 
Female             2 
Education  No education to tertiary  Ordinal No education   1 
Primary            2 
Secondary        3 
High school     4 
Tertiary            5 
Location  Urban  
Rural  
Nominal  Urban               1 
Rural                2 
Distance  Hours travelled to the health facil-
ity  
Interval  Categorised as: 
0-3.30 hours     1 
4-10 hours        2 
Economic and cultural factors  
Income Any form of monthly income  Ratio <500                 1 
500-1000          2 
>1000               3 
Language  Knowledge of any of the lan-
guages  
Nominal  Sesotho            1 
English             2 
Other                3 
Religion   Nominal  Christianity       1 
Islam                 2 
Other                 3 
Employment   Nominal  Employed          1 
Self-employed   2 





3.10 Sources of data 
 
Data was collected from patients using the study questionnaires and patients’ files were used 
for viral load tests review if need be. Laboratory results for the viral load results are in the form 
of print out in patients files or documented in patients files if received electronically or in the 
viral load register, or in patient booklet or through e-reporting which is where most of the 
results were from.  
 
3.11 Instrumentation 
Data was collected from study participants using questionnaires (Appendix 7.1 and 7.2 ). The 
study questionnaires were used so that the variables for the study could be collected from the 
participants. The study questionnaires were translated into in Sesotho (Appendix7.2) so that 
the participants could easily understand and respond to the questionnaires as expected. Ques-
tionnaires were coded so that participants could select one response from the codes. The ques-
tionnaires were divided into 4 sections which were; socio-demographic factors, reasons that 
resulted in missing ARVS, economic and cultural factors, and defaulting prevalence. The ques-
tionnaires were hand delivered to the patients as they visited the health facilities. 
 
3.12 Data collection methods 
The research assistants identified in each of the selected health facilities administered the ques-
tionnaires to the participants. The research assistants were first trained by the researcher before 
participants were enrolled into the study. Participants had a choice to either respond to the 
questionnaire before they leave the health facility or take it home and bring it when they come 
for their next monthly refill. Participants responded to the questionnaires anonymously which 
they then handed over to the research assistant. Participants were issued the questionnaires 
depending on the inclusion and exclusion criteria. The research assistants were advised to give 
health education to groups of patients in the health facilities about the purpose of the study and 
for those who volunteered to participate; further explanation about the study was given. For 
those who agreed to participate, this was followed with filling of the consent form and then 






3.13 Pilot study  
 
The research study was piloted in Mokhotlong Hospital following approval by the medical 
superintendent. Five questionnaires were used for the purpose of study pilot. The study was 
explained by the researcher to the patients accessing services at Lerato ART Centre in 
Mokhotlong Hospital. The objectives and the rational for the study were explained to the pa-
tients. Five patients volunteered to participate, and they were issued the questionnaires along 
with the information letter. Both were in Sesotho in order for them to read and understand 
before responding to the questions. No payment was made to the participants during the pilot 
study. They were informed that the study questionnaires were anonymous as they were not 
expected to mention their names or their HIV treatment unique numbers. Patients were asked 
to answer the research questionnaires and provide feedback if the questions were easy to re-
spond to or if they had any suggestions to improve the data collection instrument. They were 
given an opportunity to either respond to the questionnaires while in the health facility or take 
it home and bring it back following completion. This was done to assess if in the future partic-
ipants would prefer either method so as to minimise loss or reduced returns of the question-
naire. The given questionnaires were fully completed, and the respondents reported that the 
questionnaires were easy to respond to as they were straight forward. 
 
3.13.1 Reliability  
Reliability was measured using the five questionnaires that were given to the pilot study par-
ticipants. Test -retest method was used to measure reliability as the same questionnaires were 
given to people that participated in the pilot study. Consistency was measured based on what 
answers participants gave on the questionnaires. This was assessed using the SPSS and the 
Cronbach’s alpha. The reliability statistics  results was 0.216  which is  far from 1 as it  ranged 
between 0-1  and  possible reasons are, about 10 of the responses given are the same and 3 of 
the variables not run as they are strings and hence only 19 variables were tested for reliability. 
 
 3.13.2 Validity 
Validity was measured using five questionnaires that were given to the pilot study participants. 
This measured how the questionnaires were responded to, what they were intended to measure, 
if the participants responded to all questions, and in the responses given if there were some 
correlations among the responses. This was assessed using the SPSS version 26 and correlation 
was used to assess for validity between the variables. The results overall showed correlation 
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between the variables, except just a few that had less correlation, hence the validity of the study 
questionnaires was acceptable. Face validity was used to assess validity of the questionnaire 
since it is associated with a highest level of subjectivity as it is not based on any scientific 
approach (Dudovskiy, 2019) than the content validity which requires panel of experts to review 
and assess the tool. 
 
3.14 Data Analysis 
The research questionnaires were first checked for completeness before being entered into the 
software. Data cleaning was done to check for completeness of data and identify any missing 
values before analysis. Data was analysed using SPSS version 26 and Epi Infor 7 after com-
pletion of data collection. Epi infor 7 was used to analyse for the odds ratio and binary regres-
sion to analyse for the adjusted odds ratio. The analysis was done for continuous data and 
depicted in graphs, frequency distribution were presented in the form of bar graphs and tables 
for the variables. Binary regression was also conducted at a statistical significance of p <0.05 
and the confidence interval at 95%. The results of the analysis were presented in the form of 
odds ratio and adjusted odd ratio. The variables were categorised to ease analysis. Variables 
for the research study included; Viral load results 0-999 and 1000-1000000, Socio-economic 
factors which included age, gender, educational level, distance to the health facility and loca-
tion (rural or urban), reasons which resulted in patients missing ARVS, Economic and cultural 
factors variables included; income, employment, religion, language and finally, defaulter rate 
which focused on number of times treatment was missed. 
 
3.14.1Analysis by objectives  
Objective 1: To quantify prevalence of defaulting antiretroviral treatment among study popu-
lation, this was measured based on defaulters and non-defaulters. Frequency distribution and 
tables were used to summarize data. 
 
Objective 2: To explore why patients who have been on treatment for 6 months or more have 
high viral load despite being on antiretroviral medication at Mokhotlong District. This was 
measured by possible reasons given on questionnaires why patients may default treatment com-




Objective 3: To determine the relationship between defaulting treatment and high viral load 
among patients that are on antiretroviral medication This will be assessed based on the viral 
load laboratory results and compared to none defaulters. Frequency distribution was used to 
summarize data and binary regression was used to assess for statistical significance. 
 
Objective 4: To identify if defaulting antiretroviral treatment and high viral load differ by so-
cio-demographic factors at Mokhotlong District. This was assessed by socio-demographic fac-
tors which included; age, gender, educational level, distance to the health facility and location 
(rural or urban), etc. Cross tabulations, and logistic regression modules were used to model the 
relationship defaulting antiretroviral treatment and high viral load differ by socio-demographic 
factors. P -values and 95% confidence intervals were used to test for significance.  
 
Objective 5: To identify if economic and cultural factors contribute to poor adherence to an-
tiretroviral treatment. This was assessed based on economic and cultural factors which include 
religion and language. Cross tabulations, and logistic regression modules were e used to model 
the relationship. P-values and 95% confidence intervals were used to test for significance. 
 
3.15 Ethical Considerations 
The research proposal was submitted to University of Johannesburg Higher Degrees Commit-
tees (Appendix 7.6), Research Ethics Committee (Appendix 7.7) and Ministry of Health, Le-
sotho Research Unit (Appendix 7.11) for review and approval. 
 
3.15.1 Access to participants and document record 
Before the study started approval was requested from the Mokhotlong Hospital medical super-
intendent (Appendix 7.10), District Health Manager (Appendix 7.9) for data collection within 
the district and participants were asked to give permission of their viral load results to be used 
in the study (Appendix 7.3 and 7.4). 
3.15.2 Obtaining informed consent 
A written consent form was clearly explained to the participants and was obtained back from 
them signed before they responded to the questionnaire (Appendix7.5). Participants were in-
formed about the purpose of the study before the questionnaires were issued. They were given 
the details about the study and if they had any queries or they felt that their rights were violated 
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there were contact details of the researcher, research supervisor and the ethics committee mem-
ber. 
 3.15.3 Right to equity, human dignity and protection against harm 
Participants were not exposed to any harm and they had maximum 30 minutes to respond to 
the study questionnaires. 
3.15.4 Right to anonymity, confidentiality and privacy 
The study questionnaires were answered anonymously as no names or ART unique numbers 
were used to label the questionnaires. The information obtained was confidentially kept until 
the study was completed as no names were required. See Appendix 7.1 and 7.2. 
3.15.5 Right to freedom of choice 
An Information letter was issued so that the participants are aware that they could withdraw 
anytime they wished to as study participants, see Appendix 7.3 and 7.4. 
3.15.6 Right to community and community science 
Following study completion, results will be shared with relevant departments such as Ministry 
of Health Research Unit (DHMT) and Medical Superintendent, Mokhotlong Hospital as well 




CHAPTER 4: RESULTS 
 
4.1 Introduction 
The purpose of the study was to identify reasons why patients are defaulting on HIV treatment 
and hence result in high viral load despite being on antiretroviral treatment for at least six 
months. The study also aimed at finding the defaulting prevalence in Mokhotlong District and 
factors associated with treatment defaulting among patients on antiretroviral medication within 
the district. Questionnaires were used to answer the research questions and the sample size was 
374 of which 187 of the participants had viral load <1000 copies and 187 viral load >1000 
copies. This chapter reports the study findings. Descriptive data is presented in tables showing 
frequencies and percentages for the dependent and independent variables, mean, range, graphs 
and figures. Inferential statistics is presented showing the crude odds and adjusted odds ratio 
along with their confidence intervals. Data was analysed using SPSS and Epi infor7. 
 
4.2: Study objectives  
1. To quantify prevalence of defaulting antiretroviral treatment in study population. 
2. To explore reasons why patients that have been on treatment for six months or more 
have high viral load despite being on antiretroviral medication at Mokhotlong District. 
3. To determine the relationship between defaulting treatment and high viral load among 
patients who are on antiretroviral medication. 
4. To identify if defaulting antiretroviral treatment and high viral load differ by socio-
demographic factors in Mokhotlong District. 
5. To identify if economic and cultural factors contribute to poor adherence to antiretro-
viral treatment. 
 
4.3: Descriptive Statistics results 
 Descriptive results for defaulting prevalence and continuous data is presented. Figure 4 present 
defaulters and non-defaulters in Mokhotlong District.  
The total number of participants was N=374 and those who defaulted treatment were N=224 
and those who never defaulted N=150. Two hundred and twenty four (224) of 374 participants 
reported having defaulted on their medication, as a result the defaulter rate in Mokhotlong 
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District is 60%. This was assessed based on how the number of times a participant missed their 











Figure 4: Defaulting prevalence of ART patients in Mokhotlong district 
 
The descriptive statistics were carried out for the continuous variables in this study sample. 
Table 2 shows the descriptive analysis for continuous data, that is age, distance and viral load 
results (N=374). 
Table 2: Mean and Standard Deviation for age for ART patients in Mokhotlong  
Variable n Mean  Standard deviation 
Age  374 41.89 12.93 
Distance  374 2.25 1.61 
Viral load results 374 17460.58 73503.13 
 
Mean and standard deviation for age are 41.89 years old and 12.93, for distance 2.25 km and 
1.61 and viral load 17 460.58 copies and 73503.13 respectively.  





Figure 5:Participants age distribution for ART patients in Mokhotlong district  
Age was normally distributed in this study. The distribution is symmetric but slightly skewed 
to the right. 
 
4.4 Socio-demographic characteristics  
4.4.1 Frequency distribution for socio-demographic factors  
Frequencies and percentages for the socio demographics are presented then the odds and ad-
justed odds along with the Confidence Intervals (95% CI). Table 3 presents the participants 




Table 3: Socio Demographic Factors for Patients with High Viral Load Compared to 
Low Viral Load, Mokhotlong, Lesotho 
 Total Defaulters Never defaulted 
Characteristics n % n % n % 
Total 374 100 224 100 150 100 
Age       
18-39 years  176 47.1% 104 46.4% 72 48.0% 
≥ 40 years 198 52.9% 120 53.6% 78 52.0% 
Gender        
Male 133 35.6% 79 35.3% 54 36.0% 
Female 241 64.4% 145 64.7% 96 64.0% 
Education       
No education  51 13.6% 28 12.5% 23 15.3% 
Primary 215 57.5% 135 60.3% 80 53.3% 
Secondary 80 21.4% 43 19.2% 37 24.7% 
High school* 28 7.5% 18 8.0% 10 6.7% 
Location        
Rural 307 82.1% 186 83.0% 121 80.7% 
Urban  67 17.9% 38 17.0% 29 19.3% 
Employment        
Unemployed  250 66.8% 139 62.1% 111 74.0% 
Self -employed  72 19.3% 55 24.6% 17 11.3% 
Employed 52 13.9% 30 13.4% 22 14.7% 
Monthly income       
No income 246 65.8% 136 60.7% 110 73.3% 
<500 maloti           40 10.7% 30 13.4% 10 6.7% 
500-1000 42 11.2% 29 12.9% 13 8.7% 
>1000 46 12.3% 29 12.9% 17 11.3% 
Language        
Sesotho 373 99.7% 223 99.6% 150 100% 
English 1 0.3% 1 0.4% 0 0.0% 
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*High Tertiary added to high school, tertiary had 5 participants and high school had 23 hence 
total of 28. 
 
There were 224 participants who defaulted their medication and 150 did not default. Those 
who are in age group ≥ 40 years constituted 52.9% as compared to those between 18-39 years 
of age with 47.1%. There were more defaulters in age group ≥ 40 years as they had 120 de-
faulters (53.6%) and only 46.4% among those in age group 18-39. There were 64.7% females 
who defaulted their medication as compared to males with 35.3%. Among the education group 
those with primary education had N=135 (60.3%) of the defaulters than those with high school 
education N=18 (8.0%). Participants who resided in the rural areas had more defaulters than 
those in the urban areas with 83 % and 17 % of defaulters respectively. Sixty two per cent 
(62.1%) of those that were unemployed had defaulted as compared to the employed group 
which had 13.4% of defaulters. Those with no monthly income had 60.7% of defaulters, and 
those with monthly income < 500 (13.4%), 500-1000 (12.9%) and > 1000 (12.9%) had the least 
defaulters. Sesotho as the prevalent language had most defaulters as compared to English 
Christianity had 87.5% of defaulters as compared to the Islamic group with 7.6 % of defaulters 
while other religion was the lowest with only 4.9%.  
 
4.4.2 Defaulting prevalence in education level 
Frequency distribution for defaulting prevalence in education is presented. Figure 6 presents 
frequency distribution for defaulters and non-defaulters by their education level. 
 
Religion       
Christianity 335 89.6% 196 87.5% 139 92.7% 
Islam 22 5.9% 17 7.6% 5 3.3% 




Figure 6: Frequency distribution for ART defaulters and never defaulted in education in 
Mokhotlong district  
 
On analysing level of education and treatment defaulting, those with primary education had 
N=135 (60.3%) of the defaulters compared to those with high school education N=18 (8.0%). 
There were N=28 (12.5%) of defaulters among those with no education and N=23 (15.3%) of 
those who never defaulted. Secondary education had N=43 (19.2%) of defaulters as compared 
to N=37 (24.7%) of those who never defaulted.  
4.4.3 Defaulting prevalence by monthly income  
Frequency distribution for defaulting prevalence by monthly income is presented. Figure 7 
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Figure 7: Frequency distribution for defaulters and non-defaulters by monthly income of 
ART patients in Mokhotlong district  
Those with no monthly income had N= 136 (60.7 %) of the defaulters, and those with 
monthly income < 500 Maloti, N= 30 (13.4%), 500-1000 Maloti, N= 26 (12.9%) and > 1000 
Maloti, N=29 (12.9%) had the least defaulters.  
 
4.4.4 Statistical analysis for socio-demographic factors  
EPI Infor 7.2 was used to calculate the Odds Ratio and the Confidence Interval and logistic 
regression was used to calculate the Adjusted Odds Ratio and the Confidence Interval. The 
Odds Ratio was calculated first using the cases and the controls using 2*2 table on EPI Infor 
7.2. Thereafter possible confounding was done by conducting the adjusted odds ratios using 
SPSS binary regression models adjusting for socio-demographic characteristics. In assessing 
the relationship between defaulting medication and socio demographic factors, adjusted odds 
were computed for age, gender, education, location, employment, monthly income and reli-

















No income <500 500-1000 >1000
Monthly Income 
Defaulters Never  defaulted
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Table 4. Crude odds and adjusted odds ratio for Patients with High Viral Load Com-




95% CI* Adjusted 
Odds ratio** 
95% CI* Adjusted Odds 
Ratios 
p-value*** 
Age      
18-39 years  Reference Reference Reference Reference  
≥40 years 0.9 0.6-1.4 1.1 0.6-1.5 0.92 
Gender       
Male 1.0 0.7-1.6 0.9 0.5-1.4 0.56 
Female Reference Reference Reference Reference  
Education      
No education  1.5 0.6-3.8 0.7 0.2-2.0 0.46 
Primary 1.1 0.5-2.4 1.0 0.4-2.6 0.94 
Secondary 1.6 0.6-3.8 0.7 0.3-1.8 0.44 
High school Reference Reference Reference Reference  
Location       
Rural 0.9 0.5-1.5 1.4 0.8-2.5 0.30 
Urban  Reference Reference Reference Reference  
Employment       
Unemployed  0.9 0.5-1.7 1.1 0.5-2.4 0.84 
Self -employed  2.4 1.1-5.1 2.4 1.0-5.5 0.04 
Employed Reference Reference Reference Reference  
Monthly income     
No income 0.7  0.4-1.4 0.7 0.3-1.7 0.40 
<500 maloti           1.8 0.7-4.5 1.3 0.4-3.7 0.66 
500-1000 1.3 0.5-3.2 1.2 0.4-3.1 0.78 
>1000 Reference Reference  Reference Reference  
Religion      
Christianity Reference Reference Reference Reference  
Islam 0.4 0.2-1.2 0.4 0.1-1.2 0.11 
Other religion 0.8 0.3-2.2 1.8 0.6-5.4 0.32 
*CI=Confidence Interval 
**Adjusted by age, gender, education, location, employment, monthly income and religion 
*** P-value =0.05 
 
The results of the logistic regression show that there was no statistical association between the 
socio demographic factors and defaulting medication, except for the self-employed which were 





4.5 Medication factors and reasons for non-adherence  
4.5.1 Frequency distribution for medication factors for non-adherence 
Frequencies and percentages for medication factors and reasons for non-adherence are pre-
sented then the odds and adjusted odds along with the Confidence Intervals (95% CI). Table 
5 presents the distribution for medication factors and reasons for non-adherence for defaulters 
as well as non-defaulters. 
 
Table 5: Medication Factors and Reasons for Non-adherence for Patients with High   
Viral Load Compared to Low Viral Load, Mokhotlong, Lesotho 
 Total Defaulters  Never defaulted  
Characteristics n % n % n % 
Total 374 100 224 100 150 100 
Viral load results        
0-999 187 50.0% 77 34.4% 110 73.3% 
1000 - 1 000 000 187 50.0% 147 65.6% 40 26.7% 
Forgetfulness       
      Yes  169 45.2% 144 64.3% 25 16.7% 
       No 205 54.8% 80 35.7% 125 83.3% 
Ran out of ARVs*       
    Yes  54 14.4% 43 19.2% 11 7.3% 
    No 320 85.6% 181 80.8% 139 92.7% 
Side effects       
       Yes  17 4.5% 13 5.8% 4 2.7% 
       No 357 95.5% 211 94.2% 146 93.7% 
Sharing ARV* medications with others 
 
    
      Yes  19 5.1% 16 7.1% 3 5.1% 
      No 355 94.9% 208 92.9% 147 98.0% 
Not understanding how ARVs* work     
        Yes  44 11.8% 40 17.9% 4 2.7% 
       No 330 88.2% 184 82.2% 146 97.3% 
Lost or stolen pills       





There were 374 participants who had their viral load results available, those with viral load 
results <1000 copies were N=187 and those with viral load results > 1000 copies were 
N=187. Of the 224 participants who defaulted their medication 147 (65.6%) had viral load 
>1000 copies compared to 77 (34.4 %) that had viral load < 1000 copies. Those with high vi-
ral load and had defaulted their medication are more as compared to those who defaulted but 
did not have high viral load. Those who defaulted their treatment due to forgetfulness account 
for N=144 (64.3 % ) and those who defaulted because they ran out of ARVs made up 19.2%, 
not understanding how ARVS work, 17.9%, and had those pills falling out, 15.2%, and for 
other reasons, those accounted for less than 10% for each group of patients that had defaulted 
their medication.  
4.5.2 Statistical analysis for medication factors for non-adherence 
EPI Infor 7 was used to calculate the odds ratio and confidence intervals and logistic regres-
sion was used to calculate the adjusted odds ratio (AOR) and the Confidence Interval (CI). 
The Odds Ratio was calculated first using the cases and the controls using 2*2 table on EPI 
Infor 7. Thereafter, possible confounding was done by conducting the adjusted odds ratios us-
ing SPSS binary regression models adjusting for medication factors for non-adherence. In as-
sessing the relationship between defaulting medication and medication factors and reasons 
for non-adherence, adjusted odds were computed for age, gender, education, location, 
       No 353 94.4% 206 92.0% 147 98.0% 
Too many pills       
      Yes  15 4.0% 12 5.4% 3 2.0% 
      No 359 96.0% 212 94.6% 147 98.0% 
Pills fell out and not sure if you have to take them back    
       Yes  47 12.6% 34 15.2% 13 8.7% 
       No 327 87.4% 190 84.8% 137 91.3% 
Too ill to attend refill check-up      
    Yes    23 6.1% 19 8.5% 4 2.7% 
     No 351 93.9% 205 91.5% 146 97.3% 
Pharmacy closed before you get your 
ARVS* 
    
   Yes  21 5.6% 17 7.6% 4 2.7% 
   No 353 94.4% 207 92.4% 146 97.3% 
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employment, monthly income and religion. Table 6 presents odds ratio (OR) and adjusted 
odds ratio (AOR) for medication factors and reasons for non-adherence.  
 
Table 6: Crude and Adjusted Odds Ratios for Patients with High Viral Load Compared 
to Low Viral Load, by Medication Factors and Reasons for Non-adherence 
Characteristics Crude Odds 
ratio 
95% CI* Adjusted 
Odds ratio** 
95% CI* Adjusted 
Odds ratio 
p-value**** 
Viral load results      
0-999 5.3 3.3-8.3 6.8 4.08-11.4 0.00 
1000-1 000 000 Reference Reference Reference Reference  
Forgetfulness      
      Yes  Reference Reference Reference Reference  
      No 9.0 5.4-15.0 10.4 6.1-18.0 0.00 
Ran out of ARVs***     
    Yes  3.0 1.5-6.0 3.1 1.4-6.2 0.00 
     No Reference Reference Reference Reference  
Side effects      
     Yes  2.2 0.7-7.0 2.5 0.8-8.0 0.14 
      No Reference Reference Reference Reference  
Sharing ARV*** medications with others    
      Yes  3.8 1.1-13.2 3.3 0.9-11.9 0.07 
      No Reference  Reference Reference Reference  
Not understanding how ARVs ***work    
      Yes  7.9 2.8-22.7 9.3 3.1-27.8 0.00 
      No Reference Reference Reference Reference  
Lost or stolen pills     
      Yes  4.3 1.2-14.8 4.1 1.1-14.5 0.03 
      No Reference Reference Reference Reference  
Too many pills      
      Yes  2.8 0.8-10.0 3.0 0.8-11.5 0.11 
      No Reference Reference Reference Reference  
Pills fell out and not sure if you have to take them back   
       Yes  1.9 1.0-3.7 1.8 0.9-3.7 0.11 
       No Reference Reference Reference Reference  
Too ill to attend refill check-up    
       Yes    3.4 1.1-10.2 3.8 1.2-11.6 0.02 
       No Reference Reference Reference Reference  
Pharmacy closed before you got your ARVS***   
     Yes  3.0 1.0-9.1 3.6 0.8-8.2 0.11 
     No Reference Reference Reference Reference  
*CI=Confidence Interval 





The results of the logistic regression showed that participants with viral load results 0-999 were 
more likely to default their medication AOR 6.8, CI 4.08-11.4 (reference 1000-1000000 cop-
ies), and the relationship is statistically significant with p value 0.00. Patients were more likely 
to default their medication because they ran out of ARVs AOR 3.1, 95% CI 1.4-6.2, p value 
0.00, not understanding how ARVs work AOR 9.3, 95% CI, p value 0.00, lost or stolen pills 
AOR 4.1, 1.1-14.5 95% CI, p value 0.03, too ill to attend refill check-up AOR 3.8, 95% CI 1.2-
11.6, p value 0.02. Other factors were not statistically significant such as side effects, sharing 
ARVs, too many pills, pills fell out as well as pharmacy closure. 
 
4.6: Treatment accessibility factors to non-adherence  
4.6.1Frequency distribution for treatment accessibility to non-adherence 
Frequencies and percentages for treatment accessibility factors to non-adherence are pre-
sented then the odds and adjusted odds along with the Confidence Intervals (95% CI). Table 
7 presents the distribution for treatment accessibility factors to non-adherence for defaulters 
and non-defaulters. 
Table 7: Treatment Accessibility Factors to Non-adherence for Patients with High Viral 
Load Compared to Low Viral Load, Mokhotlong, Lesotho 
 
Participants who travelled 0-3.30 hours to the health facility accounted for 81.3% of those who 
defaulted their treatment as compared to those who travel 4-10 hours to the facility, 18.8%. 
 Total Defaulter  Never defaulted  
Characteristics n % n % n % 
Total 374 100 224 100 150 100 
Distance to health facility (hours)     
0-3.30  307 82.1% 182 81.3% 125 83.3% 
4-10  67 17.9% 42 18.8% 25 16.7% 
Travelled away from home       
      Yes  116 31.0% 99 44.2% 17 11.3% 
       No 258 69.0% 125 55.8% 133 88.7% 
Transportation problems      
      Yes  53 14.2% 46 20.5% 7 4.7% 
        No 321 85.8% 178 79.5% 143 95.3% 
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Forty four per cent (44.2%) defaulted their medication because they travelled away from home 
and those who defaulted due to transport problems were N=46 (20.5%). Figure 8 presents fre-
quency distribution for defaulters and non-defaulters by distance from health facility. 
 
Figure 8: Frequency distribution for defaulters and non-defaulters based on time travelled  for 
ART patients in Mokhotlong district  
Those who travelled a distance of 0-3.30 N =182 (81.3%) defaulted more than those who 
travel 4-10 hours N=42(18.8%).  
 
4.6.2 Statistical analysis for treatment accessibility to non-adherence 
EPI Infor 7 was used to calculate the Odds Ratio and the Confidence Interval and logistic re-
gression was used to calculate the Adjusted Odds Ratio and the Confidence Interval. The Odds 
Ratio was calculated first using the cases and the controls using 2*2 table on EPI Infor 7. 
Thereafter, possible confounding was done by conducting the adjusted odds ratios using SPSS 
binary regression models adjusting for treatment accessibility factors to non-adherence. In as-
sessing the relationship between defaulting medication and treatment accessibility factors to 
non-adherence, adjusted odds were computed for age, gender, education, location, employ-
ment, monthly income and religion. Table 8 presents Odds Ratio and Adjusted Odds Ratio for 

















0-3.30 hrs 4-10 hrs
Time (hrs)
Defaulters Never  defaulted
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Table 8: Crude odds and adjusted odds ratio for treatment accessibility factors to non-
adherence 
Characteristics Crude Odds 
ratio 
95% CI* Adjusted 
Odds ra-
tio** 
95% CI*  Adjusted 
odds ratio 
p-value*** 
Distance to health facility (hours)    
0-3.30 Reference Reference Reference Reference  
4-10 1.0 0.5-1.5 1.1 0.5-1.7 0.87 
Travelled away from home     
      Yes  6.2 3.5-11.0 7.1 3.8-13.1 0.00 
      No Reference Reference Reference Reference  
Transportation problems        
      Yes  5.3 2.3-12.1 5.8 2.5-13.5 0.00 
      No Reference Reference Reference Reference  
*CI=Confidence Interval 
** Adjusted by age, gender, education, location, employment monthly income and religion 
*** p-value=0.05 
 
Patients were more likely to default their medication because they were away from home AOR 
7.1, 95% CI 3.8-13.1, p value 0.00 and they were as well more likely to default their medication 
because they had transport challenges AOR 5.8, 95% CI 2.5-13.5, p value 0.00, however they 
did not default due to distance to the health facility AOR 1.1, 95 % CI, p value 0.87. 
 
4.7: Factors that resulted in non-adherence to treatment  
4.7.1 Frequency distribution for factors that resulted in non-adherence 
Frequencies and percentages for factors that resulted to non-adherence are presented then the 
odds and adjusted odds along with the Confidence Intervals (95% CI). Table 9 presents the 





Table 9: Factors that Resulted in Non-adherence to Treatment for Patients with High 
Viral Load Compared to Low Viral Load, Mokhotlong, Lesotho 
 
Participants reported to have defaulted their medication due to depression 41.1%, lack of 
food 24.6%, busy with other things 25.9% and fear of stigma 25.9%. Religious belief and nat-
ural disasters had less than 10% of those who defaulted medication.   
 
4.7.2Statistical analysis for factor that resulted to non-adherence  
EPI Infor 7 was used to calculate the Odds Ratio and the Confidence Interval and logistic re-
gression was used to calculate the Adjusted Odds Ratio and the Confidence Interval. The 
Odds Ratio was calculated first using the cases and the controls using 2*2 table on EPI Infor 
7. Thereafter, possible confounding was done by conducting the adjusted odds ratios using 
 Total Defaulter Never defaulted  
Characteristics n % n % n % 
Total 374 100 224 100 150 100 
Lack of food       
    Yes  78 20.9% 55 24.6% 23 15.3% 
  No 296 79.1% 169 75.4% 127 84.7% 
Religious belief/faith       
     Yes  22 5.9% 11 4.9% 11 7.3% 
    No 352 94.1% 213 95.1% 139 92.7% 
Depression or overwhelmed      
      Yes  115 30.7% 92 41.1% 23 15.3% 
      No 259 69.3% 132 58.9% 127 84.7% 
Natural disasters (fire, floods)      
      Yes  11 2.9% 9 4.0% 2 1.3% 
      No 363 97.1% 215 96.0% 148 98.7% 
Busy with other things      
      Yes  69 18.4% 58 25.9% 11 7.3% 
      No 305 81.6% 166 74.1% 139 92.7% 
Fear of stigma or discrimination within home    
     Yes  64 17.1% 58 25.9% 6 4.0% 
      No 310 82.9% 166 74.1% 144 96.0% 
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SPSS binary regression models adjusting for factors that resulted in non-adherence to treat-
ment. In assessing the relationship between defaulting medication and factors that resulted in 
non-adherence, adjusted odds were computed for age, gender, education, location, employ-
ment, monthly income and religion. Table 10 presents Odds Ratio and Adjusted Odds Ratio 
for factors that resulted in non-adherence to treatment. 
 
Table 10: Crude and Adjusted Odd Ratios for Factors that Resulted in non-adherence 
to treatment for Patients with High Viral Load Compared to Low Viral Load, 
Mokhotlong, Lesotho 
Characteristics Crude Odds 
ratio 
95% CI* Adjusted 
Odds ratio** 
95% CI*  Adjusted 
Odds ratio 
p-value*** 
Lack of food      
   Yes  1.8 1.0-3.1 2.1 1.1-3.5 0.02 
   No Reference Reference Reference Reference  
Religious belief/faith     
     Yes  0.7 0.3-1.5 0.7 0.3-1.7 0.40 
    No Reference Reference Reference Reference  
Depression or overwhelmed    
      Yes  3.8 2.3-6.5 4.7 2.7-8.3 0.00 
       No Reference Reference Reference Reference  
Natural disasters (fire, floods)    
     Yes  3.1 0.7-14.5 2.6 0.5-12.9 0.25 
      No Reference Reference Reference Reference  
Busy with other things     
      Yes  4.4 2.2-8.7 4.2 2.0-8.6 0.00 
      No Reference Reference Reference Reference  
Fear of stigma or discrimination within home   
     Yes  8.4 3.5-20.0 10.7 4.3-26.5 0.00 
      No Reference Reference Reference Reference  
*CI=Confidence Interval 
* *Adjusted by age, gender, education, location, employment monthly income and religion 
***P-value =0.05 
 
Patients with lack of food were more likely to default their medication AOR 2.1, 95% CI 1.1-
3.5, p value 0.02, depression AOR 4.7, 95% CI 2.7-8.3, p value 0.00 as well as busy with other 
things AOR 4.2, 95% CI 2.0- 8.6, p value 0.00 and fear of stigma or discrimination within 
home AOR 10.7, 95% CI 4.3-26.5, p value 0.00. Factors such as religious belief and natural 




4.8 Summary and transition 
The study was able to identify reasons that result in patients defaulting their medication and 
result in high viral load after 6 months of being on ART medication. The study found that 
defaulting prevalence in Mokhotlong District is 60 %. Research questions were used to analyse 
the results. The results show that there were more defaulters than those who never defaulted 
n=224 and n=150, respectively. There were defaulters among those with high viral load as 
compared to non-defaulters. The frequencies, tables, graphs, mean and ranges were used for 
descriptive analysis, logistic regression was used to analyse data and the OR and AOR were 
used for statistical analysis. Frequency distributions were used for descriptive analyses and 
patients were found to be defaulting their medication because of forgetfulness (64.3%), depres-
sion, (41.1%) travelled away from home (44.2%) and more defaulted due to unemployment 
(62.1%) and having no income (60.7%). Using the logistic regression AOR the following were 
found to be statistically significant; self-employed, ran out of medication, not understanding 
how ARVs work, lost or stolen pills, too ill to attend check-up, had travelled away from home, 
transport problems, depression, fear of stigma, busy with other things and lack of food. Chapter 
5 will interpret the results in detail, conclude the study, discuss strengths, limitations and rec-




CHAPTER 5: DISCUSSION 
 5.1 Introduction  
This chapter discusses the study finding, strengths, limitations and the recommendations to the 
healthcare providers and the health management team in Mokhotlong District as well as the 
Lesotho Ministry of Health. The results of the study based on the study objectives showed that 
there is high defaulting prevalence in Mokhotlong District. Socio-demographic factors did not 
have an impact on defaulting. High viral load was found to be prominent among those who 
default their medication as compared to non-defaulters. The study found that patients defaulted 
their medication because they ran-out of ARVs, they did not understand how medication works, 
were too ill to attend refill check-ups, lacked transport to travel to health facilities, would be 
far from home when medication ran out, were depressed, were busy with other things, lacked 
adequate food, feared stigma and discrimination and because their medication was lost or sto-
len. Economic and cultural factors did not have an impact in patients’ poor adherence to HIV 
treatment. 
 
 5.2 Study objectives  
1. To quantify prevalence of defaulting antiretroviral treatment in the study population. 
2. To identify if defaulting antiretroviral treatment and high viral load differ by socio-de-
mographic factors in Mokhotlong District 
3. To determine the relationship between defaulting treatment and high viral load among 
patients that are on antiretroviral medication 
4. To explore reasons why patients that have been on treatment for 6 months or more have 
high viral load despite being on antiretroviral medication in Mokhotlong District 
5. To identify if economic and cultural factors contribute to poor adherence to antiretroviral 
treatment 
 
5.3 Defaulting prevalence and factors that resulted in defaulting  
 
5.3.1 Defaulting prevalence  
Consistency in the use of antiretroviral medication is required for viral suppression and reduc-
tion in morbidity and mortality (Deribe et al., 2008). The results of the study found that de-
faulting prevalence in Mokhotlong District is high. Among the study participants, those who 
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had defaulted their treatment were more than those who never defaulted their medication and 
thus resulting in defaulting prevalence of 60% among those who participated in to the 
study.High defaulter rate result in unsuppressed viral load which is the leading cause of  high 
mortality and morbidity among ART patients . This is much way higher than the results of the 
study conducted by Deribe et al. (2008) in Ethiopia Jimma zone who found defaulting preva-
lence of 13.6 % among the study participants. This means Lesotho is prone to new HIV infec-
tions due to unsuppressed viral load by defaulters  and high mortality and morbidity among 
patients that are on ART as compared to Ethiopia. 
 
5.3.2 Socio-demographics 
The study found that patients who were self-employed were more prone to defaulting their 
medication as compared to others because of     their unstable work conditions or nature of their 
work and not being stable in one place can result in this group of people to miss their scheduled 
ART appointments and hence result in defaulting their medication . This group of patients are 
among those with low income as compared to those who are employed. These results do agree 
with the results of the studies conducted by Carballo et al. (2004) and by Barclay et al. (2007) 
where both studies found that poor adherence is more prone among patients with low financial 
status. This study found that other socio-demographic factors such as age and gender do not 
have an impact on patients defaulting their medication. This is in contrast with the study that 
was conducted by Kassahun and Zalalem (2018) who found age and gender to be contributing 
factors to poor adherence to treatment. 
5.3.3 Medication factors and reasons for non-adherence  
The results of the study found that patients with high viral load and had defaulted are more 
than those who had high viral load but never defaulted. The results revealed that 65.6% of 
patients with high viral load had defaulted and 26.7% had high viral load but never defaulted. 
The study conducted by Murphy (2003) also found more defaulters among those with high 
viral load as their results showed that patients with high viral load and had defaulted were 
44.3% and those who had high viral load and never defaulted were 22.2%. 
The results of the study found some barriers which resulted in patients not adhering well to 
their medication. Patients who reported to have defaulted their medication because they ran out 
of ARVs, their medication got lost or stolen, they were too ill to attend their check-up for refill 
and others because they did not understand how ARVs work. Previous studies conducted in 
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Botswana by Ndubuka et al. (2016) found that patients did not adhere to their medication be-
cause they ran out of pills and they did not understand the instruction on how the medication 
has to be used. The results of this study found that 19.2 % of the participants did not adhere to 
their medication because they ran out of ARVs and this is more than the results of the study by 
Ndubuka et al. (2016) who found that 11.2% did not adhere to their medication because they 
ran out of ARVs. 
The results of this study found that 17.9% of the participants did not adhere to their medication 
because they did not understand the instructions on how they are supposed to take their medi-
cation and this also is much higher than the results found by Ndubuka et al. (2016) as in their 
study only  7.7% did not adhere to their medication because they did not understand the in-
structions. This study also found that patients did not adhere to their medication because they 
got lost or they were stolen. Optimal adherence is essential in order to obtain the desired out-
comes in patients living with HIV while suboptimal adherence result in poor clinical outcomes, 
and poor quality of life and mortality (Farhoudi et al., 2018).  
The results of this study also found that patients did not adhere to their medication because 
they were too ill to go to their respective health facilities for their antiretroviral medication 
refill. The results of the study by Shubber et al. (2016) revealed that adults did not adhere to 
their medication because they were too ill to go for check-up. Their study found that 15.9% did 
not adhere due to this reasonand this was higher than what this study found as this study found 
that 8.5% of the patients did default their medication because they were too ill to go to the 
health facilities for refills. 
5.3.4 Treatment accessibility factors to non-adherence 
Further barriers that were related to defaulting treatment due to accessibility were also identi-
fied by this study. The results of the study found that patients defaulted their medication be-
cause of they had transport challenges for them to access ART services at the health facilities. 
Some studies also found that travelling, distance to the health facility and transport cost had an 
impact on patient’s non-adherence (Heestermans et al., 2016). Long distance travelled to clin-
ics is a risk factor for loss of care, and decentralization of HIV services is associated with better 
retention (Shubber et al., 2016).  
The study also found that patients defaulted their medication because they were away from 
home and could not have access their medication. Results from a study by Shubber et al. (2016) 
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also found that patients had poor adherence because they were away from home and ended up 
missing their medication. 
5.3.5 Factors that resulted in non-adherence to treatment 
Factors that resulted to non-adherence were further explored by the study. The study further 
found that patients defaulted their medication due to lack of food, depression and fear of stigma 
and discrimination within home. The study conducted by Croome et al. (2017)  in Sub-Saharan 
Africa found that lack of access to food resulted in patients’ poor adherence and this was also 
found in the study conducted in Mozambique which showed that inability to access food is a 
barrier to good adherence. This is common among African countries  and this goes along with 
what this study found that is patients defaulted their medication because of lack of food at home 
(Groh et al., 2011).  
Psychological complications such as depression have a direct impact on medication adherence 
(Farhoudi et al., 2018). The results of this study found that patients who reported to have had 
depression had defaulted in the taking of their medication and this agrees with the results of 
the study conducted by Shubber et al. (2016) which also found that patients associated with 
depression had poor adherence. 
Fear of stigma within the home was found to be among the reasons that resulted in poor adher-
ence to treatment by the study, this agrees with the results of the study conducted by Seyed-
Alinaghi et al. (2013) which found that patients did not adhere to their medication due to fear 
of stigma within the home. Croome et al. (2017) also found that patients did not adhere to their 
medication due to fear of stigma and discrimination. Furthermore, the results of Farhoudi et al. 
( 2018) found that many inmates living with HIV did not disclose their illness for the fear of 
rejection and discrimination. The behaviours by the other inmates forced the infected prisoners 
to keep their illness confidential and take their medication secretly which, in turn,  resulted in 
missing some doses. 
5.4 Application of HBM to the study 
Health Belief Model is applicable in this study as it mainly used to explore behaviours that can 
act as barriers to adherence to antiretroviral medication. There is comprehensive literature on 
factors influencing adherence to ART. Most behaviours affect adherence to ART as adherence 
is a product of motivation and ability. In order to optimize ART uptake and adherence, there is 
a need to understand why people with HIV may not want or be able to initiate and continue to 
take ART. One of the approaches is to consider the perceptions (e.g. beliefs about HIV and 
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ART) that may influence motivation together with the practicalities (e.g. capability and 
resources) influencing the ability to adhere (Glendinning et al., 2019). Lack of adherence to 
HIV treatment results in; inadequate suppression of the virus and viral replication, low potency 
of the antiretroviral regimens, and pharmacokinetic interactions causing inadequate drug 
delivery. Non-adherence jeopardizes the development of drug resistance and failure of therapy 
(Feyissa et al., 2013) hence behaviour change is essential. 
The results of the study showed that the individual factors such as depression ,being busy with 
other things and fear of stigma and discrimination play  a major in patients defaulting their 
medication and therefore patients are to change their behaviour so that they have better 
adherence to the medication. They first have to understand why they are taking their medication 
and the effects associated with defaulting medication. Those who defaulted their medication 
resulted in high viral as a result adhering to medication is key so that viral suppression can be 
attained. An individual has to understand the risk and the benefits of good/bad adherence and 
act accordingly for the benefits of good health. The patient has to first understand that 
defaulting medication can result in high viral load and progress to AIDS associated mortality 
and morbidity and therefore they can then decide to change their behaviour. 
Patients that are on lifelong ART experience many challenges, however the decision to take 
one’s treatment consistently relies solemnly with the patient. For patients’ adherence to be 
optimal, the patients should take their treatment as required. If they understand that taking ART 
is essential for their health; and with that they can adhere to their treatment as required,  other 
factors might still impact on patients’ adherence and these may include level of education, 
employment, religion and distance to the facilities. Patients with poor adherence are more likely 
to have an increase in viral load and hence result in increase in HIV associated mortality rates. 
 
5.5 Strengths of the study  
The study was conducted in 9 out of 12 facilities that offer ART services in the district resulting 
in the gathering of data from most of the patients in the district. The study was able to identify 
barriers to adherence and thus will result in appropriate decision making by those in authority. 
 
5.6 Limitations of the study  
The study was conducted in public hospital and clinics and excluded patients from the private 
clinics, who might also be facing similar challenges. Barriers were mainly focused on patients’ 
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point of view and not also of the healthcare system itself.The study focused on barriers to ad-
herence and did not find out what could be the facilitators to good adherence . 
5.7 Public health implications  
Adherence to ART result in a good quality of life and reduced HIV/AID associated mortality 
rate, therefore identifying barriers associated with poor adherence can be of great importance 
as policies that ensure that patients are assisted to maintain the expected adherence could be 
developed. By giving responses to the research questions through the responses from the ques-
tionnaire, the research will aid in establishing targets for adherence to treatment, an approach 
which is not currently in place. The results of the study can be used by the Lesotho Ministry of 
Health and the Mokhotlong District to use strategies that will help patients to adhere to the 
lifelong antiretroviral treatment. The results of the study can also enable further studies to be 
conducted as there will now be a guide on challenges that patients have. 
5.8 Conclusion  
In conclusion the results of the study showed high defaulting  prevalence among patients that 
have been on  ART for more than 6 months   and this is  supported by the high viral load results 
among the defaulters as compared to non-defaulters and thus to reach the UNAIDS 2030 95-
95-95 targets the district has to act accordingly as barriers have been identified through the 
study  .The study identified barriers to adherence as lack of food ,depression ,being away from 
home, running out of ARVS, not understanding how ARVS work ,fear of stigma and discrim-
ination ,lack of transport, being busy with other things ,lost or stolen medications and too ill to 
attend refill check-ups .With the identified barriers there is a need for patients behaviour change 
,health system modification and intensive education to patients and community as well so that 
the district can achieve the expected viral suppression and reduce HIV related morbidity and 
mortality among patients that are on ART.. 
5.9 Recommendations  
Patients reported to default because they were too ill to attend refill, some because of transport 
challenges therefore would recommend that the clinics offer ART services at all outreaches so 
that patients can access their medications without transport implications. Decentralization of 
HIV services will result in better retention and adherence among patients. Stigma seem to be 
still in existence despite having scaled up ART uptake in the country and goes without being 
noticed therefore would recommend for education especially in our communities so that people 
are more knowledgeable about HIV. HIV related stigma negatively affects many aspects of life 
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and hence government authorities, intervention is needed such as raising awareness  about 
stigma and how it impact on other people’s life  . Education on how medication works has to 
be strengthen in the facilities so that patients understands well how they are to take their med-
ication and finally, depression has to be tackled by improving on the psychosocial support or 
have a screening tool so that it can be identified in time  and patients be referred accordingly. 
There has to be a simplified way of  integrating ministry of health with ministry of social de-
velopment and agriculture so that patients that default due to lack of food can be assisted. Multi 
months dispensing for ARVS has to be strengthened so that patients that are mobile like those 
who are  self -employed cannot default their medication. 
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1.What is the age:……………………years 
 
2.Gender 
Male ……..    1 
Female……..    2 
 
3.Education 
No education…….   1 
Primary …………...   2 
Secondary ………..                            3 
High school ……….   4 
Tertiary………………  5 
 
4.Location/Residence 
Urban…….    1 
Rural………..    2 
 
5.Distance to health facility …………………Hours  
 
6.Laboratory results 
Latest viral load results……………copies 
 
Section B 
Reasons that can result in missing ARVS 
7.Forgetfulness 
Yes……       1 




8.Ran out of ARVS 
Yes……       1 
No………    2 
 
9. Lack of food 
Yes…..      1 
No…….    2 
 
10.Religious belief/faith 
Yes ……    1 
No……..    2 
 
11.Side effects 
Yes……       1 
No………    2 
 
12.Depression or overwhelmed 
 
Yes ……      1 
No……….    2 
 
13. Sharing ARV medications with others 
Yes……    1 
No…….    2 
 
14. Not understanding how ARVs work 
Yes ….       1 
No……..    2 
 
15. Travelled away from home 
Yes ……       1 
No……….    2 
 
16. Transportation problems 
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Yes….     1 
No…..     2 
 
17. Lost or stolen pills 
Yes….     1 
No…..     2 
 
18. Natural disasters(fire,floods) 
Yes ….     1 
No…….    2 
 
19. Too many pills 
Yes…..      1 
No…….    2 
 
20. Busy with other things 
Yes….     1 
No….      2 
 
21. Fear of stigma or discrimination within home 
Yes….     1 
No…       2 
 
22. Pills fell and not sure if you have to take them back 
Yes….      1 
No……    2 
 
23. Too ill to attend refill check-up 
Yes…     1 
No….     2 
 
24. Pharmacy closed before you get your ARVS 
Yes….      1 




25. Other reasons? Please specify……………… 
 
Section C 
Economic and cultural factors 
26.Monthly income: 
No income          1 
<500 maloti              2 
500-1000 maloti         3 
>1000 maloti              4 
 
27.First language 
Sesotho                                               1 
English                                                2 
Other                                                    3,specify…………………. 
 
28.Religion 
Christianity                                          1 
Islam                                                    2 
Other                                                    3 ,  Specify …… 
 
29. Employment 
Employed                                             1 
Self-employed                                      2 
Unemployed                                         3 
 
Section D  
 
Defaulting prevalence: 
30.How many times have you missed your treatment? :    
        Never                                           1 
       1-3 times                                       2 




7.2 Appendix 2 RESEARCH QUESTIONNAIRES Sesotho version 
 
Lipotso tsa boithuto 
Bo Sechaba   
1.Lilemo li kae :………………………… 
2.Boleng  
Botona                                                                       1 
Botsehali                                                                   2 
3.Thuto 
Ha kena sekolo hohang                                             1 
Thuto ea mathomo                                                    2 
Thuto e bohareng                                                      3   
Thuto e phahameng                                                  4 
Koleche/Universithi                                                  5 
4.Sebaka sa bolulo 
Teropong                                                                  1 
Mahaeng                                                                   2 
5.O tsamaea lihora tse kae  ho fihla setsing :………………………. 
6.Tlhatlhobo ea sekhahla sa kokoana-hloko 
Sephetho sa morao-rao sa sekhahla sa kokoana-hloko……………………. 
 
Karolo ea B 
Mabaka aka etsang hore o lebale honoa litlhare tse kokobetsang kokoana hloko ea HIV 
7.Bolebali 
E                                              1         
 Che                                        2 
8 .Litlhare tse kokobetsang kokoana line li felile 
E                                             1      
 Che                                       2 
9.Tlhakahalo ea lijo  
  E                                                1   
  Che                                            2 
10.Tumelo 
E                                             1  
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 Che                                              2 
11.Litla morao 
E                                                                             1 
Che                                                                         2 
12.khatello ea maikutlo 
E                                                                            1 
Che                                                                        2 
13.ke ile ka fana/arolelana ka litlhare tsaka 
E                                                                            1 
Che                                                                        2 
14.Ho hloka kutloisiso hore na litlhare li sebetsa joang 
E                                                                        1 
Che                                                                    2 
15.Kene kele hole le hae  
E                                                                        1 
Che                                                                    2 
16.Bothata ba lipalangoang 
E                                                                       1 
Che                                                                   2 
17.Litlhare line utsoitsoe kapa li lahlehile 
E                                                                       1 
Che                                                                   2 
18.Koluoa (Mollo,metsi) 
E                                                                      1 
Che                                                                  2 
19.Lipilisi li ngata haholo 
E                                                                      1 
Che                                                                  2 
20.Ke phathahane ke mabaka a mang 
E                                                                     1 
Che                                                                 2 
21.Khethollo ka lapeng 
E                                                                    1 
Che                                                                2 
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22.Pilisi e oele mme hao sa hopola haeba o ile oa e khutlisetsa ka botlolong  
E                                                                   1 
Che                                                               2 
 
23.Ono kula hahalo hoo o sitiloeng ho ea setsing  
E                                                                    1 
Che                                                                2 
 
24.Litlhareng ho koetsoe pele o fumana litlhare  
E                                                                    1 
Che                                                                2 
 
25.Mabaka a mang ho asa boleloang ka holimo, hlalosa 
……………………………………………………….. 
Karolo ea c 
Lintlha  tsa moruo le setso 
 
26.Chelete e kenang khoeli le khoeli 
Ha ho chelate e kenang                                  1 
E ka tlase ho makholo a mahlano                  2 
Makholo a mahlano ho isa seketeng              3 
Kaholimo ho sekete                                       4 
 
27.Puo ea tlhaho ea hao 
Sesotho                                                          1 
Senyesemane                                                 2 
Enngoe                                                           3 hlalosa ……………… 
 
28.Tumelo 
Mokeresete                                                    1 
Moisilamo                                                     2 





O hiriloe                                                       1 
Oa itsebetsa                                                  2 
Hao sebetse                                                  3 
Karolo ea  D  
Ho ata hoa ho lebala litlhare 
O kile oa lebala honoa litlhare makhetlo a makae: 
Hake so lebale                                            1 
 Hanngoe ho isa ho makhetlo a mararo      2 











DEPARTMENT OF ENVIRONMENTAL HEALTH 
RESEARCH STUDY INFORMATION LETTER 
REC 11.0 
 




My name is NTOISENG JULIAH CHEJANA, I would like to invite you to participate in a 
research study on BARRIERS TO ADHERENCE TO ANTIRETROVIRAL MEDICATION 
AMONG PATIENTS WITH HIGH VIRAL LOAD AS COMPARED TO LOW VIRAL 
LOAD MOKHOTLONG DISTRICT LESOTHO. 
 
Before you decide on whether to participate, I would like to explain to you why the research is 
being done and what it will involve for you. I will go through the information letter with you 
and answer any questions you have. This should take about 10 to 20 minutes. The study is part 
of a research project being completed as a requirement for a MASTER OF PUBLIC HEALTH 
Degree in ENVIRONMENTAL AND OCCUPATIONAL HEALTH through the University of 
Johannesburg. 
 
THE PURPOSE OF THIS STUDY is to find reasons that prevent you from taking your   med-
ication well.  
 
Participant Initials:______ 
Version 3.0: Approved xxxx 2018  




Below, I have compiled a set of questions and answers that I believe will assist you in under-
standing the relevant details of participation in this research study. Please read through these. 
If you have any further questions, I will be happy to answer them for you. 
 
DO I HAVE TO TAKE PART? No, you don’t have to. It is up to you to decide to participate 
in the study. I will describe the study and go through this information sheet. If you agree to 
take part, I will then ask you to sign a consent form. 
 
WHAT EXACTLY WILL I BE EXPECTED TO DO IF I AGREE TO PARTICIPATE? You 
are expected to give the permission for your viral load results to be used in the study, fill in the 
consent form, respond to the questions asked in the questionnaires and give additional infor-
mation where needed, feel free to ask questions where you don’t understand  and return them 
to the nurse or counsellor in the facility after completion. 
 
WHAT WILL YOUR RESPONSIBILITIES BE, AS THE RESEARCHER? To ensure that 
participants understand the questionnaires asked and ensure anonymity of the answers given 
by the participants. 
 
APPROXIMATELY HOW LONG WILL MY PARTICIPATION TAKE? Your participation 
will take approximately 30 minutes maximum 
 
WHAT WILL HAPPEN IF I WANT TO WITHDRAW FROM THE STUDY? If you decide 
to participate, you are free to withdraw your consent at any time without giving a reason before 
summitting the questionnaires and without any consequences however if you have submitted 
your questionnaires you cannot withdraw as the study is anonymous. If you wish to withdraw 
your consent, you should inform me as soon as possible. 
 
IF I CHOOSE TO PARTICIPATE, WILL THERE BE ANY EXPENSES FOR ME, OR PAY-
MENT DUE TO ME? You will not be paid to participate in this study and you will not bear 
any expenses 
Participant Initials:______ 
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IF I CHOOSE TO PARTICIPATE, WHAT ARE THE RISKS INVOLVED? There are no risks 
involved by participating in this study as there will be no physical harm and psychological 
harm and financially as the questionnaires can submitted in the next appointment date 
 
IF I CHOOSE TO PARTICIPATE, WHAT ARE THE BENEFITS INVOLVED? The possible 
benefit by participating is that the problems that you are facing that prevent you from taking 
your medication well will be known to the health professionals and Ministry of Health and 
measures will be taken to assist you. 
 
WILL MY PARTICIPATION IN THIS STUDY BE KEPT ANONYMOUS? All reasonable 
efforts will be made to keep your personal information anonymous and respect your right to 
privacy. You will not be identified in any research reports that are published. In addition, it 
may happen that your information will need to be reviewed by another organisation for quality 
assurance purposes. I will tell you about this if it happens. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? The results will 
be written into a research report that will be assessed. In some cases, results may also be pub-
lished in a scientific journal. In either case, you will not be identifiable in any documents, 
reports or publications. You will be given access to the results of this if you would like to see 
them, by contacting me. 
 
WHO IS ORGANISING AND FUNDING THIS RESEARCH STUDY?  The study is being 
organised by me, under the guidance of my research supervisor at the Department of Environ-
mental health at the University of Johannesburg. This study has not received any funding. 
 
WHO HAS REVIEWED AND APPROVED THIS STUDY? Before this study was allowed to 
start, it was reviewed in order to protect your interests. This review was done first by the De-
partment of Environmental health, and then secondly by the Faculty of Health Sciences Re-
search Ethics Committee at the University of Johannesburg. In both cases, the study was ap-
proved. 
Participant Initials:______ 
Version 3.0: Approved xxxx 2018  
Author: Prof. C. Stein 
WHAT IF THERE IS A PROBLEM? If you have any concerns or complaints about this re-
search study, its procedures or risks and benefits, you should ask me. You should contact me 
71 
 
at any time if you feel you have any concerns about being a part of this study. My contact 
details are: 
 




You may also contact my research supervisor: 
Professor shinga Feresu 
sferesu@gmail.com 
 
If you feel that any questions or complaints regarding your participation in this study have not 
been dealt with adequately, you may contact the Chairperson of the Faculty of Health Sciences 
Research Ethics Committee at the University of Johannesburg: 
 
Prof. Christopher Stein 
Tel: 011 559-6564 
Email: cstein@uj.ac.za 
 
FURTHER INFORMATION AND CONTACT DETAILS: Should you wish to have more 
specific information about this research project information, have any questions, concerns or 
complaints about this research study, its procedures, risks and benefits, you should communi-





Ntoiseng Juliah Chejana 
Participant Initials:______ 
Version 3.0: Approved xxxx 2018  








DEPARTMENT OF ENVIRONMENTAL HEALTH 
RESEARCH STUDY INFORMATION LETTER 
REC 11.0 
 
24 January 2020 
 
Kea u lumelisa  
 
Lebitso la ka ke Ntoiseng  Juliah Chejana ke  lakatsa ho o  memela ho nka karolo boithutong 
ba lipatlisiso  ba ho fumana hore na ke mabaka a feng a sitisang bakuli ho noa litlhare tse 
kokobetsang koakoanahloko ea HIV  ho bakuli bao sekhahla sa kokoana hloko e phahameng 
le ho bakuli bao sekhahla sa  kokoanahloko  se robetseng . 
 
Pele o nka karolo boithutong bona lintlha tsohle tse amang  boithuto  otla li hlalosetsoa pele 
mme o lokolohile ho botsa lipotso moo osa utloisising ,sena setla nka metsotso e leshome ho 
isa ho e mashome a mabeli.Boithuto bona ke karolo ea lithuto tsaka sekolong se phahameng sa 
Johannesburg. 
 
Lebaka la mantlha la boithuto bona ke ho fumana mabaka a sitisang bakuli ba sebelisang 
litlhare tse kokobetsang kokoana hloko ho linoa hantle  
 
Ka tlase  ke lethathamo la lipotso le likarabo tsetla o thusa ho utloisisa lintlha tsa boithuto bona 
ka botlalo,o li bale mme ha ona le lipotso, ketla thabela ho li araba 
Participant Initials: ______ 
Version 3.0: Approved xxxx 2018  
Author: Prof. C. Stein 
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NA KA TLAMEHILE HO NKA KAROLO BOITHUTONG BO? Che ha ooa tlameha ,ke 
boikhethelo ba hao ho nka karolo,otla fumana tlhaloso ka boithuto bona ,Mme hao lumela ho 
nka karolo , ke tla u kopa hore u tekene foromo ea tumello. 
KE LEBELETSOE HO ETSANG HA KE NKA KAROLO BOITHUTONG BOO?O 
lebeletsoe ho fana ka tumello ea hore  sephetho sa sekhahla sa hao sa  kokoana-hloko se sebe-
lisoe ele karolo ea boithuto,o tlatse foromo ea tumello, o arabe lipotso tsa boithuto le ho fana 
ka tlhaiso-leseling e eketsehileng moo ho hlokahalang  ,o botse moo osa utloising mme o 
likhutlisetse  likarabo setsing ho mooki kapa mohlabolli. 
 
BOIKARABELLO BA HAO KE BOFE OLE MOFUPUTSI? Ke ho bona hore banka karolo 
boithutong ba utloisisa lipotso tseo  ba tsoanelang holi araba,le ho bona hore likarabo tseo ba 
faneng ka tsona lia bolokeha lisa tsebahale .  
 
HO TLA NKUKA NAKO E  KAE  HO NKA KAROLO BOITHUTONG BOO? Ho tla o nka 
metsotso e mashome a mararo  kapa ka tlase ho araba lipotso tsa boithuto bona. 
HOTLA ETSAHALANG HAKE BATLA  HO SE TSOELE PELE HOBA KAROLO EA 
BOITHUTO ? Hao khetha hoba karolo ea boithuto o lokolohile ho hula tekeno ea hao ea ho 
nka karolo pele o khutlisa lipotso tse botsitsoeng  ntle le litlamorao tsa letho empa haose o 
khutlisitse lipotso, hao satla hula boitekeno kaha litaba tse fanoeng ho keke hoa eba bobebe ho 
likhetholla ho tse seng li fanoe ,Mme hao batla ho itokolla o ntlalehele hang-hang . 
 
HAKE NKA KAROLO BOITHUTONG BOO NA KETLABA LE LITJEO KAPA HONA HO 
FUMANA TEFO? U ke ke oa lefelloa ho nka karolo boithutong bona e 'me u ke ke ua kena  
litšenyehelong ka ho nka karolo. 
HAKE NKA KAROLO BOITHUTONG BOO NA HONA LE LITLA MORAO TSE MPE 
TSE KA NKAMANG? Ha ho na likotsi tse amehang ka ho nka karolo thutong ena kaha ho ke 
ke ha ba le kotsi ea 'mele le ho lemala kelellong le licheleteng joalo ka ha lipampiri tsa lipotso 
li ka sala setsing hang hang kapa oa li  romella ka letsatsi le latelang la tumellano. 
HAKE NKA KAROLO BOITHUTONG BOO MELEMO E AMEHENAG KE EFE? Melemo 
eka lebelloang ka ho nka karolo boithutong bona ke hore basebeletsi ba lekala la bophelo le  
lekala  la bophelo batla fumana mathata a le sitisang honoa litlhare mme batla etsa meralo etla 
le thusa. 
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NA HO NKA KAROLO TABA TSAKA LITLA BOLOKOA LISA TSEBAHALE?Mekutu 
eohle etla etsoa ho boloka litaba tsena li sa tsebahale .Haho moo boitsebiso ba hao botla hlaha 
li tlalehong tsa boithuto bona. Ntle le moo, ho ka etsahala hore tlhahiso leseling ea hau e tla 
hloka ho hlahlojoa ke mokhatlo o mong bakeng sa sepheo sa netefatso ea boleng. Ke tla u 
bolella ka sena haeba se etsahala. 
 
HO TLA ETSAHALANG KA SEPHETHO SA BOITHUTO BOO? Liphetho li tla ngolloa 
tlalehong ea lipatlisiso tse tla hlahlojoa, mme maemong amang setla sebelisoa phatlalatsong ea 
boithuto mme haho moo boitsebiso ba haobotla hlaha. U tla fuoa monyetla oa ho fumana 
liphetho tsa sena haeba u rata ho li bona, ka ho ikopanya le nna. 
 
KE MANG MOHLOPHISI OA BOITHUTO LE MOTS’EHETSI OA LICHELETE? Boithuto 
bona bo hlophisoa ke nna moithuti tlasa botataisi ba morupelli sekolong se phahameng sa Jo-
hannesburg.Boithuto bona haho mang kapa mang abo ts’ehelitseng ka lichelete. 
 
KE MANG EA HLAHLOBILENG LE HO FANA KA TUMELLO EA BOITHUTO 
BOO?Pele boithuto bona bo qata bo hlahlobuoe ho sireletsa lithahasello tsa hao.Tlhatlhobo ena 
e entsoe  pele ke lefapha la bphelo bo botle ba tikoloho le komiti ea lipatlisiso tsa mahlale 
sekolong se phahameng sa Johannesburg.Maemong ao ale mabeli boithuto bona bo fumane 
tumello ea hore bo tsoelepele. 
 
HA EBA HO ENA LE BOTHATA? Haeba u na le matšoenyeho kapa litletlebo mabapi le thuto 
ena ea lipatlisiso, mekhoa ea eona kapa likotsi tsa eona le melemo, o lokela ho mpotsa. O lokela 
ho ikopanya le nna ka nako efe kapa efe haeba o ikutloa hore o na le matšoenyeho a ho ba 
karolo ea thuto ena. Lintlha tsa ka tsa puisano ke : 
Ntoiseng Juliah Chejana 
00266 58479908 
ntoiseng@yahoo.com 
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Professor shinga Feresu 
sferesu@gmail.com 
 
Haeba o na le maikutlo a hore lipotso kapa litletlebo mabapi le ho nka karolo ha hao thutong 
ena ha liea  rarolloa ka nepo, o ka ikopanya le Molula-setulo oa Komiti ea Litekanyetso tsa 
Boithuto ba Bophelo Univesithing ea Johannesburg  mona: 
Prof. Christopher Stein 
Tel: 011 559-6564 
Email: cstein@uj.ac.za 
 
Bakeng sa lintlha ka botlalo boithutong bona ekaba lipotso kapa tlhakisetso ka litla morao le 
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DEPARTMENT OF ENVIRONMENTAL HEALTH 
RESEARCH CONSENT FORM 
REC 11.0 
 
BARRIERS TO ADHERENCE TO ANTIRETROVIRAL MEDICATION AMONG PA-
TIENTS WITH HIGH VIRAL LOAD AS COMPARED TO LOW VIRAL LOAD IN 
MKHOTLONG DISTRICT, LESOTHO 
 
Please initial each box below: 
 
 
I confirm that I have read and understand the information letter dated 25.09.19 for the above 
study. I have had the opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
I understand that my participation is voluntary and that I am free to withdraw from this study 
at any time without giving any reason and without any consequences to me. 
 
 








_______________________       _______________________________  ________________ 





_______________________        _____________________                 ________________ 













7.7 Appendix 7-Approval letter REC 
 
                                                 
  
FACULTY OF HEALTH SCIENCES  
RESEARCH ETHICS COMMITTEE  
  
NHREC Registration: REC 241112-035  
  
ETHICAL CLEARANCE LETTER  






Student Number  218100853  
Supervisor Name  Feresu, Shingairai  
Department  Environmental Health  
Research Title  
BARRIERS TO ADHERENCE TO ANTIRETROVIRAL MEDI-
CATION AMONG PATIENTS  
WITH HIGH VIRAL LOAD COMPARED TO LOW VIRAL 
LOAD, MOKHOTLONG, LESOTHO  




Approval of the research proposal with details given above is granted, subject to any condi-
tions under 1 below, and is valid until 2021/03/01.  
  
1. Conditions:  
None.  
  
2. Renewal:   
It is required that this ethical clearance is renewed annually, within two weeks of the date in-
dicated above. Renewal must be done using the Ethical Clearance Renewal Form (REC 10.0), 
to be completed and submitted to the Faculty Administration office. See Section 12 of the 
REC Standard Operating Procedures.  
  
3. Amendments:  
Any envisaged amendments to the research proposal that has been granted ethical clearance 
must be submitted to the REC using the Research Proposal Amendment Application Form 
(REC 8.0) prior to the research being amended. Amendments to research may only be carried 
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out once a new ethical clearance letter is issued. See Section 13 of the REC Standard Operat-
ing Procedures.  
  
4. Adverse Events, Deviations or Non-compliance:  
Adverse events, research proposal deviations or non-compliance must be reported within the 
stipulated time-frames using the Adverse Event Reporting Form (REC 9.0). See Section 14 of 
the REC Standard Operating Procedures.  
  
The REC wishes you all the best for your studies.  
  
Yours sincerely.  
 
  
Prof. Christopher Stein  
Chairperson: REC  
Tel: 011 559 6564  
Email: cstein@uj.ac.za  
  
RECX 2.0 – Faculty of Health Sciences    Secretariat: Ms Raihaanah Pieterse  
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7.9 Appendix 9-Approval letter DMHT  
 
 
                                                                        Mokhotlong DHMT 
                        P.O BOX 107 
Mokhotlong 500                                                             
27/03/20 
To: Ntoiseng Juliah Chejana 
P.O Box 373 
Botha-Bothe 400 
RE-REQUEST FOR PERMISSON TO CONDUCT A RESEARCH STUDY IN 
MOKHOTLONG DISTRICT 
Reference is made to your letter dated 24 January 2020, we would like to appreciate 
your choice regarding our district for your research study . We hope this is going to 
help the district for its development and growth for health benefit of the community 
we serve as a district from your feedback. 
You are therefore allowed to proceed with your research study practicing in line with 









MINISTRY OF HEALTH 
D.H.M.T. 
27 MAR 2020 
P.o. BOX 107 
D.M.O. MOKHOTLONG 




7.10 Appendix 10-Approval letter medical superintendent  
 
                                                                Mokhotlong Government Hosp  
                                                                  P. O. Box 107 
Mokhotlong 500. 
14/03/2020. 
To: Ntoiseng Juliah Chejana 
P.O Box 373 
Botha-Bothe 400 
RE: REQUEST FOR PERMISSION TO CONDUCT A RESEARCH STUDY IN 
MOKHOTLONG GOVERNMENT HOSPITAL. 
Reference made to yourletter dated 24 January 2020, we would like to thank you for 
choosing our Institution for your study and to tell you that we don't have any objec-
tion for that as long as the study is going to benefit the Hospital in particular and the 
District in general. 
We are expecting a feedback from this study; not only a presentation of a summary 
but also a copy of the report that hospital will keep jealously for the future use. 
Good luckFOR MOKHOTLONG HOSPITAL 










                                                                                              Ministry of Health  




Date: May 27, 2020 
To 
Ntoiseng Julian Chejana 
University of Johannesburg 
Dear, Miss Chejana, 
RE: Barriers to Adherence to Antiretroviral Medication among Patients with high 
Viral Load Compared to Low Viral Load, Mokhotlong, Lesotho. 
This is to inform you that the Ministry of Health Research and Ethics Committee re-
viewed and APPROVED the above-named protocol and hereby authorizes you to con-
duct the study according to the activities and population specified in the protocol. De-
parture from the approved protocol will constitute a breach of this permission. 
This approval includes review of the following 
attachments. [x] Protocol 
[x] English informed consent form 
[x] Data collection tools in English and Sesotho 
[ ] Participant materials [insert types, 
versions] [xl Other materials: Letter of 
request for approval 
This approval is VALID until May 28, 2021. 
Please note that an annual report and request for renewal, if applicable, must be sub-
mitted at least 6 weeks before the expiry date. 
All serious adverse events associated with this study must be reported promptly to 
the MOH Research and Ethics Committee. Any modifications to the approved proto-
col or consent forms must be submitted to the committee prior to implementation of 
any changes. 
Category of Review: 
[x] Initial Review 




[ ] Reactivation 
[ J Serious Adverse Event 
[ ] Other  
85 
 
We look forward to receiving your progress reports and a final report at the end of 
the study. If you have any questions, please contact the Research and Ethics Com-
mittee at (or) 22226317. 
Sincerely, 
DR. NYANE LETSIE  
Director General Health Services 
 
DR. LIMPHO MAILE 
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Proposal and questionnaire De-
velopment 
       
Complete research proposal 
submission 
       
Correction of research after 
HDC Comments 
   
 
    
Resubmission to HDC        
Ethical and HDC clearance        
Data Collection        
Data Analysis and Interpreta-
tion 
       
Report Writing        
Submission of research report        














7.13 Appendix 13: Budget costs  
ITEM  DESCRIPTION  AMOUNT 
TRAVELLING COSTS 
 Hired car  8 trips R6,000 
PERSONNEL   
 Study assistants  NA R3,500 
EQUPMENTS COSTS 
 Printing Questionnaire and informed consent papers N/A R3,600 
 Envelopes N/A R500 
 Data and airtime  N/A R1300 
STATISTICAL ANALYSIS 
 SPSS software N/A N/A 
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